<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38399736</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>04</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Potential Beneficial Effects of Naringin and Naringenin on Long COVID-A Review of the Literature.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">332</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms12020332</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) caused a severe epidemic due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Recent studies have found that patients do not completely recover from acute infections, but instead, suffer from a variety of post-acute sequelae of SARS-CoV-2 infection, known as long COVID. The effects of long COVID can be far-reaching, with a duration of up to six months and a range of symptoms such as cognitive dysfunction, immune dysregulation, microbiota dysbiosis, myalgic encephalomyelitis/chronic fatigue syndrome, myocarditis, pulmonary fibrosis, cough, diabetes, pain, reproductive dysfunction, and thrombus formation. However, recent studies have shown that naringenin and naringin have palliative effects on various COVID-19 sequelae. Flavonoids such as naringin and naringenin, commonly found in fruits and vegetables, have various positive effects, including reducing inflammation, preventing viral infections, and providing antioxidants. This article discusses the molecular mechanisms and clinical effects of naringin and naringenin on treating the above diseases. It proposes them as potential drugs for the treatment of long COVID, and it can be inferred that naringin and naringenin exhibit potential as extended long COVID medications, in the future likely serving as nutraceuticals or clinical supplements for the comprehensive alleviation of the various manifestations of COVID-19 complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Siqi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-Evaluation of Post-Market Traditional Chinese Medicine, State Key Laboratory of Biocontrol, Guangdong Provincial Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Mengli</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-Evaluation of Post-Market Traditional Chinese Medicine, State Key Laboratory of Biocontrol, Guangdong Provincial Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-Evaluation of Post-Market Traditional Chinese Medicine, State Key Laboratory of Biocontrol, Guangdong Provincial Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-Evaluation of Post-Market Traditional Chinese Medicine, State Key Laboratory of Biocontrol, Guangdong Provincial Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maoming Branch, Guangdong Laboratory for Lingnan Modern Agriculture, Maoming 525000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yonggang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-Evaluation of Post-Market Traditional Chinese Medicine, State Key Laboratory of Biocontrol, Guangdong Provincial Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Peibo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-Evaluation of Post-Market Traditional Chinese Medicine, State Key Laboratory of Biocontrol, Guangdong Provincial Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023A1515011953</GrantID><Agency>Natural Science Foundation of Guangdong Province</Agency><Country/></Grant><Grant><GrantID>2022SDZG07</GrantID><Agency>Open Competition Program of Ten Major Directions of Agricultural Science and Technology Innovation for the 14th Five-Year Plan of Guangdong Province</Agency><Country/></Grant><Grant><GrantID>2022ZD006</GrantID><Agency>Research Fund of Maoming Branch, Guangdong Laboratory for Lingnan Modern Agriculture</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">beneficial effects</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">naringenin</Keyword><Keyword MajorTopicYN="N">naringin</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38399736</ArticleId><ArticleId IdType="pmc">PMC10892048</ArticleId><ArticleId IdType="doi">10.3390/microorganisms12020332</ArticleId><ArticleId IdType="pii">microorganisms12020332</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yu I.T.S., Li Y., Wong T.W., Tam W., Chan A.T., Lee J.H.W., Leung D.Y.C., Ho T. Evidence of Airborne Transmission of the Severe Acute Respiratory Syndrome Virus. N. Engl. J. Med. 2004;350:1731&#x2013;1739. doi: 10.1056/NEJMoa032867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa032867</ArticleId><ArticleId IdType="pubmed">15102999</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J., Sun W., Huang J., Gamber M., Wu J., He G. Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020. Emerg. Infect. Dis. 2020;26:1343&#x2013;1345. doi: 10.3201/eid2606.200412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2606.200412</ArticleId><ArticleId IdType="pmc">PMC7258486</ArticleId><ArticleId IdType="pubmed">32163030</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva F.A.F., de Brito B.B., Santos M.L.C., Marques H.S., da Silva Junior R.T., de Carvalho L.S., de Sousa Cruz S., Rocha G.R., Santos G.L.C., de Souza K.C., et al. Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Fecal-Oral: Current Knowledge. World J. Clin. Cases. 2021;9:8280&#x2013;8294. doi: 10.12998/wjcc.v9.i28.8280.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v9.i28.8280</ArticleId><ArticleId IdType="pmc">PMC8554441</ArticleId><ArticleId IdType="pubmed">34754839</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., Si H.-R., Zhu Y., Li B., Huang C.-L., et al. A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature. 2020;579:270&#x2013;273. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S., Casaro E.B., Rangel &#xc9;.B. COVID-19: Angiotensin-Converting Enzyme 2 (ACE2) Expression and Tissue Susceptibility to SARS-CoV-2 Infection. Eur. J. Clin. Microbiol. Infect. Dis. 2021;40:905&#x2013;919. doi: 10.1007/s10096-020-04138-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Ahmad Farouk I., Lal S.K. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2021;13:202. doi: 10.3390/v13020202.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020202</ArticleId><ArticleId IdType="pmc">PMC7911532</ArticleId><ArticleId IdType="pubmed">33572857</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Operational Planning Guidance to Support Country Preparedness and Response.  [(accessed on 20 December 2023)].  Available online:  https://www.who.int/publications-detail-redirect/draft-operational-planning-guidance-for-un-country-teams.</Citation></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus&#x2013;Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta E.M., Batra A., Clark J.R., Shlobin N.A., Hoffman S.C., Orban Z.S., Koralnik I.J. Frequent Neurologic Manifestations and Encephalopathy-associated Morbidity in COVID-19 Patients. Ann. Clin. Transl. Neurol. 2020;7:2221&#x2013;2230. doi: 10.1002/acn3.51210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51210</ArticleId><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y., Rong L., Nian W., He Y. Review Article: Gastrointestinal Features in COVID-19 and the Possibility of Faecal Transmission. Aliment. Pharmacol. Ther. 2020;51:843&#x2013;851. doi: 10.1111/apt.15731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.15731</ArticleId><ArticleId IdType="pmc">PMC7161803</ArticleId><ArticleId IdType="pubmed">32222988</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Julg B., Mohandas S., Bradfute S.B. Viral Persistence, Reactivation, and Mechanisms of Long COVID. eLife. 2023;12:e86015. doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., Levitan E.B., Levy B., McComsey G.A., McCorkell L., Nadkarni G.N., Parthasarathy S., Singh U., et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023;329:1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingery J.R., Safford M.M., Martin P., Lau J.D., Rajan M., Wehmeyer G.T., Li H.A., Alshak M.N., Jabri A., Kofman A., et al. Health Status, Persistent Symptoms, and Effort Intolerance One Year after Acute COVID-19 Infection. J. Gen. Intern. Med. 2022;37:1218&#x2013;1225. doi: 10.1007/s11606-021-07379-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07379-z</ArticleId><ArticleId IdType="pmc">PMC8786200</ArticleId><ArticleId IdType="pubmed">35075531</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerksieck P., Ballouz T., Haile S.R., Schumacher C., Lacy J., Domenghino A., Fehr J.S., Bauer G.F., Dressel H., Puhan M.A., et al. Post COVID-19 Condition, Work Ability and Occupational Changes in a Population-Based Cohort. Lancet Reg. Health-Eur. 2023;31:100671. doi: 10.1016/j.lanepe.2023.100671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100671</ArticleId><ArticleId IdType="pmc">PMC10287546</ArticleId><ArticleId IdType="pubmed">37366496</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study. Lancet. 2023;401:e21&#x2013;e33. doi: 10.1016/S0140-6736(23)00810-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00810-3</ArticleId><ArticleId IdType="pmc">PMC10258565</ArticleId><ArticleId IdType="pubmed">37321233</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or Post-COVID-19 Syndrome: Putative Pathophysiology, Risk Factors, and Treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T., Menges D., Anagnostopoulos A., Domenghino A., Aschmann H.E., Frei A., Fehr J.S., Puhan M.A. Recovery and Symptom Trajectories up to Two Years after SARS-CoV-2 Infection: Population Based, Longitudinal Cohort Study. BMJ. 2023;381:e074425. doi: 10.1136/bmj-2022-074425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-074425</ArticleId><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostanci A., Gazi U., Tosun O., Suer K., Unal Evren E., Evren H., Sanlidag T. Long-COVID-19 in Asymptomatic, Non-Hospitalized, and Hospitalized Populations: A Cross-Sectional Study. J. Clin. Med. 2023;12:2613. doi: 10.3390/jcm12072613.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12072613</ArticleId><ArticleId IdType="pmc">PMC10095523</ArticleId><ArticleId IdType="pubmed">37048697</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm L.K., Nielsen S.S.F., Pahus M.H., Frattari G.S., Olesen R., Andersen R., Monrad I., Andersen A.H.F., Thomsen M.M., Konrad C.V., et al. SARS-CoV-2 Persistence Is Associated with Antigen-Specific CD8 T-Cell Responses. EBioMedicine. 2021;64:103230. doi: 10.1016/j.ebiom.2021.103230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103230</ArticleId><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J., Laurence J. Long COVID Endotheliopathy: Hypothesized Mechanisms and Potential Therapeutic Approaches. J. Clin. Investig. 2022;132:e161167. doi: 10.1172/JCI161167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID Following Mild SARS-CoV-2 Infection: Characteristic T Cell Alterations and Response to Antihistamines. J. Investig. Med. Off. Publ. Am. Fed. Clin. Res. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Noonong K., Chatatikun M., Surinkaew S., Kotepui M., Hossain R., Bunluepuech K., Noothong C., Tedasen A., Klangbud W.K., Imai M., et al. Mitochondrial Oxidative Stress, Mitochondrial ROS Storms in Long COVID Pathogenesis. Front. Immunol. 2023;14:1275001. doi: 10.3389/fimmu.2023.1275001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1275001</ArticleId><ArticleId IdType="pmc">PMC10766822</ArticleId><ArticleId IdType="pubmed">38187378</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S., Kril I., Nadizhko O., Matsyura O., Chopyak V. Herpesvirus Infections and Post-COVID-19 Manifestations: A Pilot Observational Study. Rheumatol. Int. 2022;42:1523&#x2013;1530. doi: 10.1007/s00296-022-05146-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05146-9</ArticleId><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;lvarez-Santacruz C., Tyrkalska S.D., Candel S. The Microbiota in Long COVID. Int. J. Mol. Sci. 2024;25:1330. doi: 10.3390/ijms25021330.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25021330</ArticleId><ArticleId IdType="pmc">PMC10816132</ArticleId><ArticleId IdType="pubmed">38279329</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A., Vasaikar S.V., Szeto G.L., Lemos M.P., Czartoski J.L., MacMillan H., Moodie Z., Cohen K.W., Fleming L.B., Thomson Z., et al. Persistent Serum Protein Signatures Define an Inflammatory Subcategory of Long COVID. Nat. Commun. 2023;14:3417. doi: 10.1038/s41467-023-38682-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38682-4</ArticleId><ArticleId IdType="pmc">PMC10252177</ArticleId><ArticleId IdType="pubmed">37296110</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae. Cell. 2022;185:881&#x2013;895. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., Sperhake J.P., Schr&#xf6;der A.S., Edler C., Mushumba H., Fitzek A., Allweiss L., Dandri M., et al. Neuropathology of Patients with COVID-19 in Germany: A Post-Mortem Case Series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S., Nath A. Nervous System Consequences of COVID-19. Science. 2022;375:267&#x2013;269. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Halim A., Halim M., Ming L.C., Goh K.W., Alfaresi M., AlShehail B.M., Al Fares M.A., Alissa M., Sulaiman T., et al. Experimental Drugs in Randomized Controlled Trials for Long-COVID: What&#x2019;s in the Pipeline? A Systematic and Critical Review. Expert Opin. Investig. Drugs. 2023;32:655&#x2013;667. doi: 10.1080/13543784.2023.2242773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2023.2242773</ArticleId><ArticleId IdType="pubmed">37534972</ArticleId></ArticleIdList></Reference><Reference><Citation>Khubber S., Hashemifesharaki R., Mohammadi M., Gharibzahedi S.M.T. Garlic (Allium Sativum L.): A Potential Unique Therapeutic Food Rich in Organosulfur and Flavonoid Compounds to Fight with COVID-19. Nutr. J. 2020;19:124. doi: 10.1186/s12937-020-00643-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12937-020-00643-8</ArticleId><ArticleId IdType="pmc">PMC7673072</ArticleId><ArticleId IdType="pubmed">33208167</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh M.V., Francis S., Aktay S., Kralovich G., Raghavendran K. Therapeutic Potential of Curcumin in ARDS and COVID-19. Clin. Exp. Pharmacol. Physiol. 2023;50:267&#x2013;276. doi: 10.1111/1440-1681.13744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1440-1681.13744</ArticleId><ArticleId IdType="pmc">PMC9877870</ArticleId><ArticleId IdType="pubmed">36480131</ArticleId></ArticleIdList></Reference><Reference><Citation>Imran M., Khan S.A., Abida, Alshammari M.K., Alkhaldi S.M., Alshammari F.N., Kamal M., Alam O., Asdaq S.M.B., Alzahrani A.K., et al. Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature. Molecules. 2022;27:2750. doi: 10.3390/molecules27092750.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27092750</ArticleId><ArticleId IdType="pmc">PMC9105261</ArticleId><ArticleId IdType="pubmed">35566101</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakkir Maideen N.M., Hassan Jumale A., Ramadan Barakat I., Khalifa Albasti A. Potential of Black Seeds (Nigella Sativa) in the Management of Long COVID or Post-Acute Sequelae of COVID-19 (PASC) and Persistent COVID-19 Symptoms&#x2014;An Insight. Infect. Disord. Drug Targets. 2023;23:e230223213955. doi: 10.2174/1871526523666230223112045.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871526523666230223112045</ArticleId><ArticleId IdType="pubmed">36825730</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathinavel T., Palanisamy M., Srinivasan P., Subramanian A., Thangaswamy S. Phytochemical 6-Gingerol-A Promising Drug of Choice for COVID-19. Int. J. Adv. Sci. Eng. 2020;6:1482&#x2013;1489. doi: 10.29294/IJASE.6.4.2020.1482-1489.</Citation><ArticleIdList><ArticleId IdType="doi">10.29294/IJASE.6.4.2020.1482-1489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A.M., Kunugi H. Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of in Silico, in Vitro, and Clinical Studies. Molecules. 2021;26:1232. doi: 10.3390/molecules26051232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26051232</ArticleId><ArticleId IdType="pmc">PMC7956496</ArticleId><ArticleId IdType="pubmed">33669054</ArticleId></ArticleIdList></Reference><Reference><Citation>Melrose J., Smith M.M. Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive Decline. Front. Biosci. 2022;14:27. doi: 10.31083/j.fbe1404027.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.fbe1404027</ArticleId><ArticleId IdType="pubmed">36575843</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzuti B., Ceballos-Laita L., Ortega-Alarcon D., Jimenez-Alesanco A., Vega S., Grande F., Conforti F., Abian O., Velazquez-Campoy A. Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds. Pharmaceuticals. 2021;14:892. doi: 10.3390/ph14090892.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14090892</ArticleId><ArticleId IdType="pmc">PMC8465303</ArticleId><ArticleId IdType="pubmed">34577592</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinaccio L., Stefanucci A., Scioli G., Della Valle A., Zengin G., Cichelli A., Mollica A. Peptide Human Neutrophil Elastase Inhibitors from Natural Sources: An Overview. Int. J. Mol. Sci. 2022;23:2924. doi: 10.3390/ijms23062924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23062924</ArticleId><ArticleId IdType="pmc">PMC8954713</ArticleId><ArticleId IdType="pubmed">35328340</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y., Peng W., Yang C., Zou W., Liu M., Wu H., Fan L., Li P., Zeng X., Su W. Pharmacokinetics and Metabolism of Naringin and Active Metabolite Naringenin in Rats, Dogs, Humans, and the Differences between Species. Front. Pharmacol. 2020;11:364. doi: 10.3389/fphar.2020.00364.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00364</ArticleId><ArticleId IdType="pmc">PMC7118210</ArticleId><ArticleId IdType="pubmed">32292344</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles E.A., Calder P.C. Effects of Citrus Fruit Juices and Their Bioactive Components on Inflammation and Immunity: A Narrative Review. Front. Immunol. 2021;12:712608. doi: 10.3389/fimmu.2021.712608.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.712608</ArticleId><ArticleId IdType="pmc">PMC8264544</ArticleId><ArticleId IdType="pubmed">34249019</ArticleId></ArticleIdList></Reference><Reference><Citation>Stabrauskiene J., Kopustinskiene D.M., Lazauskas R., Bernatoniene J. Naringin and Naringenin: Their Mechanisms of Action and the Potential Anticancer Activities. Biomedicines. 2022;10:1686. doi: 10.3390/biomedicines10071686.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10071686</ArticleId><ArticleId IdType="pmc">PMC9313440</ArticleId><ArticleId IdType="pubmed">35884991</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Xue Y., Jia G., Zhao H., Liu G., Huang Z. Antifatigue Effect of Naringin on Improving Antioxidant Capacity and Mitochondrial Function and Preventing Muscle Damage. Exp. Biol. Med. 2022;247:1776&#x2013;1784. doi: 10.1177/15353702221117128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15353702221117128</ArticleId><ArticleId IdType="pmc">PMC9638954</ArticleId><ArticleId IdType="pubmed">36112949</ArticleId></ArticleIdList></Reference><Reference><Citation>Casacchia T., Occhiuzzi M.A., Grande F., Rizzuti B., Granieri M.C., Rocca C., Gattuso A., Garofalo A., Angelone T., Statti G. A Pilot Study on the Nutraceutical Properties of the Citrus Hybrid Tacle&#xae; as a Dietary Source of Polyphenols for Supplementation in Metabolic Disorders. J. Funct. Foods. 2019;52:370&#x2013;381. doi: 10.1016/j.jff.2018.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2018.11.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidary Moghaddam R., Samimi Z., Moradi S.Z., Little P.J., Xu S., Farzaei M.H. Naringenin and Naringin in Cardiovascular Disease Prevention: A Preclinical Review. Eur. J. Pharmacol. 2020;887:173535. doi: 10.1016/j.ejphar.2020.173535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173535</ArticleId><ArticleId IdType="pubmed">32910944</ArticleId></ArticleIdList></Reference><Reference><Citation>AmeliMojarad M., AmeliMojarad M. Interleukin-6 Inhibitory Effect of Natural Product Naringenin Compared to a Synthesised Monoclonal Antibody against Life-Threatening COVID-19. Rev. Med. Virol. 2023;33:e2445. doi: 10.1002/rmv.2445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2445</ArticleId><ArticleId IdType="pubmed">37029557</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal P.K., Agrawal C., Blunden G. Naringenin as a Possible Candidate against SARS-CoV-2 Infection and in the Pathogenesis of COVID-19. Nat. Prod. Commun. 2021;16:1934578X211066723. doi: 10.1177/1934578X211066723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1934578X211066723</ArticleId></ArticleIdList></Reference><Reference><Citation>Tutunchi H., Naeini F., Ostadrahimi A., Hosseinzadeh-Attar M.J. Naringenin, a Flavanone with Antiviral and Anti-inflammatory Effects: A Promising Treatment Strategy against COVID-19. Phytother. Res. 2020;34:3137&#x2013;3147. doi: 10.1002/ptr.6781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6781</ArticleId><ArticleId IdType="pmc">PMC7361426</ArticleId><ArticleId IdType="pubmed">32613637</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleebrahim-Dehkordi E., Ghoshouni H., Koochaki P., Esmaili-Dehkordi M., Aleebrahim E., Chichagi F., Jafari A., Hanaei S., Heidari-Soureshjani E., Rezaei N. Targeting the Vital Non-Structural Proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and Inhibition of RNA Polymerase by Natural Bioactive Compound Naringenin as a Promising Drug Candidate against COVID-19. J. Mol. Struct. 2023;1287:135642. doi: 10.1016/j.molstruc.2023.135642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molstruc.2023.135642</ArticleId><ArticleId IdType="pmc">PMC10131750</ArticleId><ArticleId IdType="pubmed">37131962</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias-Guiu J.A., Herrera E., Gonz&#xe1;lez-Nosti M., Krishnan K., Delgado-Alonso C., D&#xed;ez-Cirarda M., Yus M., Mart&#xed;nez-Petit &#xc1;., Pag&#xe1;n J., Mat&#xed;as-Guiu J., et al. Development of Criteria for Cognitive Dysfunction in Post-COVID Syndrome: The IC-CoDi-COVID Approach. Psychiatry Res. 2023;319:115006. doi: 10.1016/j.psychres.2022.115006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.115006</ArticleId><ArticleId IdType="pubmed">36521337</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., Suen J., Robba C., Fraser J., Cho S.-M. Mid and Long-Term Neurological and Neuropsychiatric Manifestations of Post-COVID-19 Syndrome: A Meta-Analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiss A.B., Greene C., Dayaramani C., Rauchman S.H., Stecker M.M., De Leon J., Pinkhasov A. Long COVID, the Brain, Nerves, and Cognitive Function. Neurol. Int. 2023;15:821&#x2013;841. doi: 10.3390/neurolint15030052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15030052</ArticleId><ArticleId IdType="pmc">PMC10366776</ArticleId><ArticleId IdType="pubmed">37489358</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and Cognitive Impairment in Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N., Zhao Y.-M., Yan W., Li C., Lu Q.-D., Liu L., Ni S.-Y., Mei H., Yuan K., Shi L., et al. A Systematic Review and Meta-Analysis of Long Term Physical and Mental Sequelae of COVID-19 Pandemic: Call for Research Priority and Action. Mol. Psychiatry. 2023;28:423&#x2013;433. doi: 10.1038/s41380-022-01614-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01614-7</ArticleId><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheetham N.J., Penfold R., Giunchiglia V., Bowyer V., Sudre C.H., Canas L.S., Deng J., Murray B., Kerfoot E., Antonelli M., et al. The Effects of COVID-19 on Cognitive Performance in a Community-Based Cohort: A COVID Symptom Study Biobank Prospective Cohort Study. EClinicalMedicine. 2023;62:102086. doi: 10.1016/j.eclinm.2023.102086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102086</ArticleId><ArticleId IdType="pmc">PMC10466229</ArticleId><ArticleId IdType="pubmed">37654669</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Jin L., Zhang M., Wu Y., Duan Z., Guo Y., Wang C., Guo Y., Chen W., Liao Z., et al. Blood&#x2013;Brain Barrier Injury and Neuroinflammation Induced by SARS-CoV-2 in a Lung&#x2013;Brain Microphysiological System. Nat. Biomed. Eng. 2023:1&#x2013;16. doi: 10.1038/s41551-023-01054-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-023-01054-w</ArticleId><ArticleId IdType="pubmed">37349391</ArticleId></ArticleIdList></Reference><Reference><Citation>Soung A.L., Vanderheiden A., Nordvig A.S., Sissoko C.A., Canoll P., Mariani M.B., Jiang X., Bricker T., Rosoklija G.B., Arango V., et al. COVID-19 Induces CNS Cytokine Expression and Loss of Hippocampal Neurogenesis. Brain. 2022;145:4193&#x2013;4201. doi: 10.1093/brain/awac270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac270</ArticleId><ArticleId IdType="pmc">PMC9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Kim T.W., Han Y., Nair M.S., Harschnitz O., Zhu J., Wang P., Koo S.Y., Lacko L.A., Chandar V., et al. SARS-CoV-2 Infection Causes Dopaminergic Neuron Senescence. Cell Stem Cell. 2024:S1934590923004423. doi: 10.1016/j.stem.2023.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2023.12.012</ArticleId><ArticleId IdType="pmc">PMC10843182</ArticleId><ArticleId IdType="pubmed">38237586</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavanagh E. Long COVID Brain Fog: A Neuroinflammation Phenomenon? Oxf. Open Immunol. 2022;3:iqac007. doi: 10.1093/oxfimm/iqac007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfimm/iqac007</ArticleId><ArticleId IdType="pmc">PMC9914477</ArticleId><ArticleId IdType="pubmed">36846556</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurel E., Toups M., Nemeroff C.B. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron. 2020;107:234&#x2013;256. doi: 10.1016/j.neuron.2020.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.06.002</ArticleId><ArticleId IdType="pmc">PMC7381373</ArticleId><ArticleId IdType="pubmed">32553197</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A., Shah M., Ahmad S.A., Premraj L., Wildi K., Li Bassi G., Pardo C.A., Choi A., Cho S.-M. Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Cells. 2023;12:816. doi: 10.3390/cells12050816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xf6;bstel A.-K., Schirmer L. SARS-CoV-2-Specific Neuropathology: Fact or Fiction? Trends Neurosci. 2021;44:933&#x2013;935. doi: 10.1016/j.tins.2021.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2021.10.006</ArticleId><ArticleId IdType="pmc">PMC8519811</ArticleId><ArticleId IdType="pubmed">34716032</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J., Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., et al. Neuropilin-1 Facilitates SARS-CoV-2 Cell Entry and Infectivity. Science. 2020;370:856&#x2013;860. doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan M., Wang X., Gong M., Wang Q., Li Y., Jia J. Post-COVID Cognitive Dysfunction: Current Status and Research Recommendations for High Risk Population. Lancet Reg. Health West. Pac. 2023;38:100836. doi: 10.1016/j.lanwpc.2023.100836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2023.100836</ArticleId><ArticleId IdType="pmc">PMC10344681</ArticleId><ArticleId IdType="pubmed">37457901</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J., Msika E.-F., Queneau M., Farid K., Paquet C. Long COVID: Cognitive Complaints (Brain Fog) and Dysfunction of the Cingulate Cortex. J. Neurol. 2022;269:44&#x2013;46. doi: 10.1007/s00415-021-10655-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.C., Devason A.S., Umana I.C., Cox T.O., Dohnalov&#xe1; L., Litichevskiy L., Perla J., Lundgren P., Etwebi Z., Izzo L.T., et al. Serotonin Reduction in Post-Acute Sequelae of Viral Infection. Cell. 2023;186:4851&#x2013;4867. doi: 10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwatra M., Kumar V., Jangra A., Mishra M., Ahmed S., Ghosh P., Vohora D., Khanam R. Ameliorative Effect of Naringin against Doxorubicin-Induced Acute Cardiac Toxicity in Rats. Pharm. Biol. 2016;54:637&#x2013;647. doi: 10.3109/13880209.2015.1070879.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13880209.2015.1070879</ArticleId><ArticleId IdType="pubmed">26471226</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouri Z., Fakhri S., El-Senduny F.F., Sanadgol N., Abd-ElGhani G.E., Farzaei M.H., Chen J.-T. On the Neuroprotective Effects of Naringenin: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective. Biomolecules. 2019;9:690. doi: 10.3390/biom9110690.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9110690</ArticleId><ArticleId IdType="pmc">PMC6920995</ArticleId><ArticleId IdType="pubmed">31684142</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Liu R., He J., Li J., Guo J., Chen Y., Ji K. Naringin Regulates Microglia BV-2 Activation and Inflammation via the JAK/STAT3 Pathway. Evid.-Based Complement. Altern. Med. 2022;2022:3492058. doi: 10.1155/2022/3492058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/3492058</ArticleId><ArticleId IdType="pmc">PMC9135528</ArticleId><ArticleId IdType="pubmed">35646153</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddell J.R. Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration? Antioxidants. 2017;6:65. doi: 10.3390/antiox6030065.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox6030065</ArticleId><ArticleId IdType="pmc">PMC5618093</ArticleId><ArticleId IdType="pubmed">28820437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G.-Q., Zhang B., He X.-M., Li D.-D., Shi J.-S., Zhang F. Naringenin Targets on Astroglial Nrf2 to Support Dopaminergic Neurons. Pharmacol. Res. 2019;139:452&#x2013;459. doi: 10.1016/j.phrs.2018.11.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2018.11.043</ArticleId><ArticleId IdType="pubmed">30527894</ArticleId></ArticleIdList></Reference><Reference><Citation>Salman M., Sharma P., Alam M.d.I., Tabassum H., Parvez S. Naringenin Mitigates Behavioral Alterations and Provides Neuroprotection against 3-Nitropropinoic Acid-Induced Huntington&#x2019;s Disease like Symptoms in Rats. Nutr. Neurosci. 2022;25:1898&#x2013;1908. doi: 10.1080/1028415X.2021.1913319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2021.1913319</ArticleId><ArticleId IdType="pubmed">33856270</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Zhang Y., Liu Y., Niu X. Naringenin Attenuates Cognitive Impairment in a Rat Model of Vascular Dementia by Inhibiting Hippocampal Oxidative Stress and Inflammatory Response and Promoting N-Methyl-D-Aspartate Receptor Signaling Pathway. Neurochem. Res. 2022;47:3402&#x2013;3413. doi: 10.1007/s11064-022-03696-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-022-03696-9</ArticleId><ArticleId IdType="pubmed">36028734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Prakash A., Dogra S. Naringin Alleviates Cognitive Impairment, Mitochondrial Dysfunction and Oxidative Stress Induced by D-Galactose in Mice. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2010;48:626&#x2013;632. doi: 10.1016/j.fct.2009.11.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2009.11.043</ArticleId><ArticleId IdType="pubmed">19941926</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwatra M., Jangra A., Mishra M., Sharma Y., Ahmed S., Ghosh P., Kumar V., Vohora D., Khanam R. Naringin and Sertraline Ameliorate Doxorubicin-Induced Behavioral Deficits through Modulation of Serotonin Level and Mitochondrial Complexes Protection Pathway in Rat Hippocampus. Neurochem. Res. 2016;41:2352&#x2013;2366. doi: 10.1007/s11064-016-1949-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-016-1949-2</ArticleId><ArticleId IdType="pubmed">27209303</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahdavinia M., Ahangarpour A., Zeidooni L., Samimi A., Alizadeh S., Dehghani M.A., Alboghobeish S. Protective Effect of Naringin on Bisphenol A-Induced Cognitive Dysfunction and Oxidative Damage in Rats. Int. J. Mol. Cell. Med. 2019;8:141&#x2013;153. doi: 10.22088/IJMCM.BUMS.8.2.141.</Citation><ArticleIdList><ArticleId IdType="doi">10.22088/IJMCM.BUMS.8.2.141</ArticleId><ArticleId IdType="pmc">PMC7081084</ArticleId><ArticleId IdType="pubmed">32215265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour L.A.H., Elshopakey G.E., Abdelhamid F.M., Albukhari T.A., Almehmadi S.J., Refaat B., El-Boshy M., Risha E.F. Hepatoprotective and Neuroprotective Effects of Naringenin against Lead-Induced Oxidative Stress, Inflammation, and Apoptosis in Rats. Biomedicines. 2023;11:1080. doi: 10.3390/biomedicines11041080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11041080</ArticleId><ArticleId IdType="pmc">PMC10135523</ArticleId><ArticleId IdType="pubmed">37189698</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips C. Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection. Neural. Plast. 2017;2017:7260130. doi: 10.1155/2017/7260130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7260130</ArticleId><ArticleId IdType="pmc">PMC5591905</ArticleId><ArticleId IdType="pubmed">28928987</ArticleId></ArticleIdList></Reference><Reference><Citation>Esvald E.-E., Tuvikene J., Sirp A., Patil S., Bramham C.R., Timmusk T. CREB Family Transcription Factors Are Major Mediators of BDNF Transcriptional Autoregulation in Cortical Neurons. J. Neurosci. 2020;40:1405&#x2013;1426. doi: 10.1523/JNEUROSCI.0367-19.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0367-19.2019</ArticleId><ArticleId IdType="pmc">PMC7044735</ArticleId><ArticleId IdType="pubmed">31915257</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Lu R.-R., Xu R.-H., Wang H.-H., Feng W.-S., Zheng X.-K. Naringenin and Apigenin Ameliorates Corticosterone-Induced Depressive Behaviors. Heliyon. 2023;9:e15618. doi: 10.1016/j.heliyon.2023.e15618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e15618</ArticleId><ArticleId IdType="pmc">PMC10192682</ArticleId><ArticleId IdType="pubmed">37215924</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L.-T., Li J., Li H.-C., Su D.-X., Quan X.-B., He X.-C., Wang X.-H. Antidepressant-like Behavioral, Neurochemical and Neuroendocrine Effects of Naringenin in the Mouse Repeated Tail Suspension Test. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2012;39:175&#x2013;181. doi: 10.1016/j.pnpbp.2012.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2012.06.009</ArticleId><ArticleId IdType="pubmed">22709719</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A.S., Sushma P., Dharmashekar C., Beelagi M.S., Prasad S.K., Shivamallu C., Prasad A., Syed A., Marraiki N., Prasad K.S. In Silico Evaluation of Flavonoids as Effective Antiviral Agents on the Spike Glycoprotein of SARS-CoV-2. Saudi J. Biol. Sci. 2021;28:1040&#x2013;1051. doi: 10.1016/j.sjbs.2020.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjbs.2020.11.049</ArticleId><ArticleId IdType="pmc">PMC7783825</ArticleId><ArticleId IdType="pubmed">33424398</ArticleId></ArticleIdList></Reference><Reference><Citation>Sette A., Crotty S. Adaptive Immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184:861&#x2013;880. doi: 10.1016/j.cell.2021.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC7803150</ArticleId><ArticleId IdType="pubmed">33497610</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major Findings, Mechanisms and Recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J.R., Dhodapkar R.M., Lu P., Gehlhausen J.R., Tabachnikova A., Greene K., Tabacof L., Malik A.A., et al. Distinguishing Features of Long COVID Identified through Immune Profiling. Nature. 2023;623:139&#x2013;148. doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong J.-G., Ravishankar A., Sharma S., Parkhurst C.N., Grassmann S.A., Wingert C.K., Laurent P., Ma S., Paddock L., Miranda I.C., et al. Epigenetic Memory of Coronavirus Infection in Innate Immune Cells and Their Progenitors. Cell. 2023;186:3882&#x2013;3902.e24. doi: 10.1016/j.cell.2023.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.07.019</ArticleId><ArticleId IdType="pmc">PMC10638861</ArticleId><ArticleId IdType="pubmed">37597510</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Ward S.E., Townsend L., Karampini E., Elliott S., Conlon N., Dunne J., Kiersey R., Naughton A., Gardiner M., et al. Sustained VWF-ADAMTS-13 Axis Imbalance and Endotheliopathy in Long COVID Syndrome Is Related to Immune Dysfunction. J. Thromb. Haemost. 2022;20:2429&#x2013;2438. doi: 10.1111/jth.15830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15830</ArticleId><ArticleId IdType="pmc">PMC9349977</ArticleId><ArticleId IdType="pubmed">35875995</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Naughton A., Kiersey R., Holden D., Gardiner M., Dowds J., O&#x2019;Brien K., Bannan C., Nadarajan P., et al. Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health. Front. Immunol. 2021;12:676932. doi: 10.3389/fimmu.2021.676932.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.676932</ArticleId><ArticleId IdType="pmc">PMC8138306</ArticleId><ArticleId IdType="pubmed">34025675</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological Dysfunction Persists for 8 Months Following Initial Mild-to-Moderate SARS-CoV-2 Infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumi T., Harada K. Immune Response to SARS-CoV-2 in Severe Disease and Long COVID-19. iScience. 2022;25:104723. doi: 10.1016/j.isci.2022.104723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104723</ArticleId><ArticleId IdType="pmc">PMC9251893</ArticleId><ArticleId IdType="pubmed">35813874</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber C.N., Patel R.S., Trachtman R., Lepow L., Amanat F., Krammer F., Wilson K.M., Onel K., Geanon D., Tuballes K., et al. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (Mis-c) Cell. 2020;183:982&#x2013;995. doi: 10.1016/j.cell.2020.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.034</ArticleId><ArticleId IdType="pmc">PMC7489877</ArticleId><ArticleId IdType="pubmed">32991843</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse Functional Autoantibodies in Patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., F&#xfc;rst J., Schulze-Rothe S., Wallukat A., H&#xf6;nicke A.-S., M&#xfc;ller J. Functional Autoantibodies against G-Protein Coupled Receptors in Patients with Persistent Long-COVID-19 Symptoms. J. Transl. Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Novelli L., Motta F., De Santis M., Ansari A.A., Gershwin M.E., Selmi C. The JANUS of Chronic Inflammatory and Autoimmune Diseases Onset during COVID-19&#x2014;A Systematic Review of the Literature. J. Autoimmun. 2021;117:102592. doi: 10.1016/j.jaut.2020.102592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102592</ArticleId><ArticleId IdType="pmc">PMC7833462</ArticleId><ArticleId IdType="pubmed">33401171</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Niu X., Wang J. Naringenin as a Natural Immunomodulator against T Cell-Mediated Autoimmune Diseases: Literature Review and Network-Based Pharmacology Study. Crit. Rev. Food Sci. Nutr. 2022;63:11026&#x2013;11043. doi: 10.1080/10408398.2022.2092054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2022.2092054</ArticleId><ArticleId IdType="pubmed">35776085</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H.-K., Yeh C.-H., Iwamoto T., Satsu H., Shimizu M., Totsuka M. Dietary Flavonoid Naringenin Induces Regulatory T Cells via an Aryl Hydrocarbon Receptor Mediated Pathway. J. Agric. Food Chem. 2012;60:2171&#x2013;2178. doi: 10.1021/jf204625y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf204625y</ArticleId><ArticleId IdType="pubmed">22324845</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Yamane H., Paul W.E. Differentiation of Effector CD4 T Cell Populations. Annu. Rev. Immunol. 2010;28:445&#x2013;489. doi: 10.1146/annurev-immunol-030409-101212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-030409-101212</ArticleId><ArticleId IdType="pmc">PMC3502616</ArticleId><ArticleId IdType="pubmed">20192806</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu X., Wu C., Li M., Zhao Q., Meydani S.N., Wang J., Wu D. Naringenin Is an Inhibitor of T Cell Effector Functions. J. Nutr. Biochem. 2018;58:71&#x2013;79. doi: 10.1016/j.jnutbio.2018.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2018.04.008</ArticleId><ArticleId IdType="pubmed">29885599</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Niu X., Wu C., Wu D. Naringenin Modifies the Development of Lineage-Specific Effector CD4+ t Cells. Front. Immunol. 2018;9:2267. doi: 10.3389/fimmu.2018.02267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02267</ArticleId><ArticleId IdType="pmc">PMC6174281</ArticleId><ArticleId IdType="pubmed">30327657</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y.-P., Wen J.-J., Zhao X.-X., Gao Y.-C., Ma X., Song S.-Y., Jin Y., Shao T.-J., Yu J., Wen C.-P. The Flavonoid Naringenin Alleviates Collagen-Induced Arthritis through Curbing the Migration and Polarization of Cd4+ t Lymphocyte Driven by Regulating Mitochondrial Fission. Int. J. Mol. Sci. 2022;24:279. doi: 10.3390/ijms24010279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24010279</ArticleId><ArticleId IdType="pmc">PMC9820519</ArticleId><ArticleId IdType="pubmed">36613721</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrego-Peredo A., Romero-Ram&#xed;rez H., Espinosa E., L&#xf3;pez-Herrera G., Garc&#xed;a-Garc&#xed;a F., Flores-Mu&#xf1;oz M., Sandoval-Montes C., Rodr&#xed;guez-Alba J.C. Naringenin Mitigates Autoimmune Features in Lupus-Prone Mice by Modulation of T-Cell Subsets and Cytokines Profile. PLoS ONE. 2020;15:e0233138. doi: 10.1371/journal.pone.0233138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0233138</ArticleId><ArticleId IdType="pmc">PMC7233587</ArticleId><ArticleId IdType="pubmed">32421738</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Qi Y., Niu X., Tang H., Meydani S.N., Wu D. Dietary Naringenin Supplementation Attenuates Experimental Autoimmune Encephalomyelitis by Modulating Autoimmune Inflammatory Responses in Mice. J. Nutr. Biochem. 2018;54:130&#x2013;139. doi: 10.1016/j.jnutbio.2017.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2017.12.004</ArticleId><ArticleId IdType="pubmed">29331869</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng W., Jin L., Zhang F., Zhang C., Liang W. Naringenin as a Potential Immunomodulator in Therapeutics. Pharmacol. Res. 2018;135:122&#x2013;126. doi: 10.1016/j.phrs.2018.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2018.08.002</ArticleId><ArticleId IdType="pubmed">30081177</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin L., Zeng W., Zhang F., Zhang C., Liang W. Naringenin Ameliorates Acute Inflammation by Regulating Intracellular Cytokine Degradation. J. Immunol. 2017;199:3466&#x2013;3477. doi: 10.4049/jimmunol.1602016.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1602016</ArticleId><ArticleId IdType="pubmed">28993518</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C.-Y., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut Microbiota Composition Reflects Disease Severity and Dysfunctional Immune Responses in Patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Lau R.I., Liu Q., Su Q., Chan F.K.L., Ng S.C. Gut Microbiota in COVID-19: Key Microbial Changes, Potential Mechanisms and Clinical Applications. Nat. Rev. Gastroenterol. Hepatol. 2023;20:323&#x2013;337. doi: 10.1038/s41575-022-00698-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00698-4</ArticleId><ArticleId IdType="pmc">PMC9589856</ArticleId><ArticleId IdType="pubmed">36271144</ArticleId></ArticleIdList></Reference><Reference><Citation>de Ana Patr&#xed;cia O., Lopes A.L.F., Pacheco G., de S&#xe1; Guimar&#xe3;es Nol&#xea;to I.R., Nicolau L.A.D., Medeiros J.V.R. Premises among SARS-CoV-2, Dysbiosis and Diarrhea: Walking through the ACE2/mTOR/Autophagy Route. Med. Hypotheses. 2020;144:110243. doi: 10.1016/j.mehy.2020.110243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110243</ArticleId><ArticleId IdType="pmc">PMC7467124</ArticleId><ArticleId IdType="pubmed">33254549</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S., Chen Y., Wu Z., Chen Y., Gao H., Lv L., Guo F., Zhang X., Luo R., Huang C., et al. Alterations of the Gut Microbiota in Patients with COVID-19 or H1n1 Influenza. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2020;71:ciaa709. doi: 10.1093/cid/ciaa709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa709</ArticleId><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong H., Wang Y., Shi Z., Zhang L., Ren H., He W., Zhang Z., Zhu A., Zhao J., Xiao F., et al. Characterization of Respiratory Microbial Dysbiosis in Hospitalized COVID-19 Patients. Cell Discov. 2021;7:23. doi: 10.1038/s41421-021-00257-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00257-2</ArticleId><ArticleId IdType="pmc">PMC8043102</ArticleId><ArticleId IdType="pubmed">33850111</ArticleId></ArticleIdList></Reference><Reference><Citation>Soffritti I., D&#x2019;Accolti M., Fabbri C., Passaro A., Manfredini R., Zuliani G., Libanore M., Franchi M., Contini C., Caselli E. Oral Microbiome Dysbiosis Is Associated with Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study. Front. Microbiol. 2021;12:687513. doi: 10.3389/fmicb.2021.687513.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.687513</ArticleId><ArticleId IdType="pmc">PMC8261071</ArticleId><ArticleId IdType="pubmed">34248910</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardelli C., Gentile I., Setaro M., Di Domenico C., Pinchera B., Buonomo A.R., Zappulo E., Scotto R., Scaglione G.L., Castaldo G., et al. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium Periodonticum? Front. Cell. Infect. Microbiol. 2021;11:625581. doi: 10.3389/fcimb.2021.625581.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.625581</ArticleId><ArticleId IdType="pmc">PMC7919745</ArticleId><ArticleId IdType="pubmed">33659220</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Gu S., Chen Y., Lu H., Shi D., Guo J., Wu W.-R., Yang Y., Li Y., Xu K.-J., et al. Six-Month Follow-up of Gut Microbiota Richness in Patients with COVID-19. Gut. 2022;71:222&#x2013;225. doi: 10.1136/gutjnl-2021-324090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324090</ArticleId><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhang J., Zhang D., Ma W.-L., Wang X. Linking the Gut Microbiota to Persistent Symptoms in Survivors of COVID-19 after Discharge. J. Microbiol. 2021;59:941&#x2013;948. doi: 10.1007/s12275-021-1206-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12275-021-1206-5</ArticleId><ArticleId IdType="pmc">PMC8356893</ArticleId><ArticleId IdType="pubmed">34382150</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N., Takeuchi T., Masuoka H., Aoki R., Ishikane M., Iwamoto N., Sugiyama M., Suda W., Nakanishi Y., Terada-Hirashima J., et al. Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications. Gastroenterology. 2023;164:272&#x2013;288. doi: 10.1053/j.gastro.2022.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.09.024</ArticleId><ArticleId IdType="pmc">PMC9499989</ArticleId><ArticleId IdType="pubmed">36155191</ArticleId></ArticleIdList></Reference><Reference><Citation>de Gislane Lelis Vilela O., Oliveira C.N.S., Pinzan C.F., de Salis L.V.V., Cardoso C.R.d.B. Microbiota Modulation of the Gut-Lung Axis in COVID-19. Front. Immunol. 2021;12:635471. doi: 10.3389/fimmu.2021.635471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.635471</ArticleId><ArticleId IdType="pmc">PMC7945592</ArticleId><ArticleId IdType="pubmed">33717181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Vitetta L. The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes. Front. Biosci. Sch. Ed. 2022;14:23. doi: 10.31083/j.fbs1403023.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.fbs1403023</ArticleId><ArticleId IdType="pubmed">36137978</ArticleId></ArticleIdList></Reference><Reference><Citation>Carloni S., Bertocchi A., Mancinelli S., Bellini M., Erreni M., Borreca A., Braga D., Giugliano S., Mozzarelli A.M., Manganaro D., et al. Identification of a Choroid Plexus Vascular Barrier Closing during Intestinal Inflammation. Science. 2021;374:439&#x2013;448. doi: 10.1126/science.abc6108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6108</ArticleId><ArticleId IdType="pubmed">34672740</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng W., Ao H., Peng C., Yan D. Gut Microbiota, a New Frontier to Understand Traditional Chinese Medicines. Pharmacol. Res. 2019;142:176&#x2013;191. doi: 10.1016/j.phrs.2019.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.02.024</ArticleId><ArticleId IdType="pubmed">30818043</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H., Zhang D., Wu J., Liu J., Zhou Y., Tan Y., Feng W., Peng C. Interactions between Gut Microbiota and Polyphenols: A Mechanistic and Metabolomic Review. Phytomedicine Int. J. Phytother. Phytopharm. 2023;119:154979. doi: 10.1016/j.phymed.2023.154979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2023.154979</ArticleId><ArticleId IdType="pubmed">37552899</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Yao X., Zhou Q., Meng X., Zhou T., Gu Q. Citrus Peel Flavonoid Extracts: Health-Beneficial Bioactivities and Regulation of Intestinal Microecology in Vitro. Front. Nutr. 2022;9:888745. doi: 10.3389/fnut.2022.888745.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.888745</ArticleId><ArticleId IdType="pmc">PMC9171401</ArticleId><ArticleId IdType="pubmed">35685878</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Ye H., Pi X., Liu W., Wang Z., Zhang Y., Zheng J. Effects of Several Flavonoids on Human Gut Microbiota and Its Metabolism by in Vitro Simulated Fermentation. Front. Microbiol. 2023;14:1092729. doi: 10.3389/fmicb.2023.1092729.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1092729</ArticleId><ArticleId IdType="pmc">PMC9932666</ArticleId><ArticleId IdType="pubmed">36819019</ArticleId></ArticleIdList></Reference><Reference><Citation>Firrman J., Liu L., Argoty G.A., Zhang L., Tomasula P., Wang M., Pontious S., Kobori M., Xiao W. Analysis of Temporal Changes in Growth and Gene Expression for Commensal Gut Microbes in Response to the Polyphenol Naringenin. Microbiol. Insights. 2018;11:1178636118775100. doi: 10.1177/1178636118775100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1178636118775100</ArticleId><ArticleId IdType="pmc">PMC6044793</ArticleId><ArticleId IdType="pubmed">30013359</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Song Z.-G., Liu C., Tan S., Lin S., Zhu J., Dai F.-H., Gao J., She J.-L., Mei Z., et al. Gut Microbiome Alterations and Gut Barrier Dysfunction Are Associated with Host Immune Homeostasis in COVID-19 Patients. BMC Med. 2022;20:24. doi: 10.1186/s12916-021-02212-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02212-0</ArticleId><ArticleId IdType="pmc">PMC8769945</ArticleId><ArticleId IdType="pubmed">35045853</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Guo H., Pan X., Huang R., Wang G., Liu J. Naringin Exhibited Therapeutic Effects against DSS-Induced Mice Ulcerative Colitis in Intestinal Barrier&#x2013;Dependent Manner. Molecules. 2021;26:6604. doi: 10.3390/molecules26216604.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26216604</ArticleId><ArticleId IdType="pmc">PMC8588024</ArticleId><ArticleId IdType="pubmed">34771012</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S., Nora-Krukle Z., Henning N., Eliassen E., Shikova E., Harrer T., Scheibenbogen C., Murovska M., Prusty B.K. Chronic Viral Infections in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) J. Transl. Med. 2018;16:268. doi: 10.1186/s12967-018-1644-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Renz-Polster H., Scheibenbogen C. Post-COVID-Syndrom Mit Fatigue Und Belastungsintoleranz: Myalgische Enzephalomyelitis Bzw. Chronisches Fatigue-Syndrom. Inn. Med. 2022;63:830&#x2013;839. doi: 10.1007/s00108-022-01369-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00108-022-01369-x</ArticleId><ArticleId IdType="pmc">PMC9281337</ArticleId><ArticleId IdType="pubmed">35925074</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. ME/CFS and Long COVID Share Similar Symptoms and Biological Abnormalities: Road Map to the Literature. Front. Med. 2023;10:1187163. doi: 10.3389/fmed.2023.1187163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Bateman L. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front. Med. 2021;7:606824. doi: 10.3389/fmed.2020.606824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Y., Zhang T., Cai J., Huang C., Zhan S., Liu J. Bioinformatics and Systems Biology Approach to Identify the Pathogenetic Link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Immunol. 2022;13:952987. doi: 10.3389/fimmu.2022.952987.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.952987</ArticleId><ArticleId IdType="pmc">PMC9524193</ArticleId><ArticleId IdType="pubmed">36189286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H., Quach T.C., Tiwari A., Bonilla A.E., Miglis M., Yang P.C., Eggert L.E., Sharifi H., Horomanski A., Subramanian A., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Common in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC): Results from a Post-COVID-19 Multidisciplinary Clinic. Front. Neurol. 2023;14:1090747. doi: 10.3389/fneur.2023.1090747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Wu Y., Meng X., Wang Z., Younis M., Liu Y., Wang P., Huang X. SARS-CoV-2 Membrane Protein Causes the Mitochondrial Apoptosis and Pulmonary Edema via Targeting BOK. Cell Death Differ. 2022;29:1395&#x2013;1408. doi: 10.1038/s41418-022-00928-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-00928-x</ArticleId><ArticleId IdType="pmc">PMC8752586</ArticleId><ArticleId IdType="pubmed">35022571</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Resendiz K.J.G., Benitez-Trinidad A.B., Covantes-Rosales C.E., Toledo-Ibarra G.A., Ortiz-Lazareno P.C., Gir&#xf3;n-P&#xe9;rez D.A., Bueno-Dur&#xe1;n A.Y., P&#xe9;rez-D&#xed;az D.A., Barcelos-Garc&#xed;a R.G., Gir&#xf3;n-P&#xe9;rez M.I. Loss of Mitochondrial Membrane Potential (&#x394;&#x3a8; m) in Leucocytes as post-COVID-19 Sequelae. J. Leukoc. Biol. 2022;112:23&#x2013;29. doi: 10.1002/JLB.3MA0322-279RRR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3MA0322-279RRR</ArticleId><ArticleId IdType="pmc">PMC9088601</ArticleId><ArticleId IdType="pubmed">35355308</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller B., Silverstein A., Flores M., Cao K., Kumagai H., Mehta H.H., Yen K., Kim S.-J., Cohen P. Host Mitochondrial Transcriptome Response to SARS-CoV-2 in Multiple Cell Models and Clinical Samples. Sci. Rep. 2021;11:3. doi: 10.1038/s41598-020-79552-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-79552-z</ArticleId><ArticleId IdType="pmc">PMC7794290</ArticleId><ArticleId IdType="pubmed">33420163</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelman B., Charlton B.T., Goulding R.P., Kerkhoff T.J., Breedveld E.A., Noort W., Offringa C., Bloemers F.W., Van Weeghel M., Schomakers B.V., et al. Muscle Abnormalities Worsen after Post-Exertional Malaise in Long COVID. Nat. Commun. 2024;15:17. doi: 10.1038/s41467-023-44432-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-44432-3</ArticleId><ArticleId IdType="pmc">PMC10766651</ArticleId><ArticleId IdType="pubmed">38177128</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves-Filho A.M., Braniff O., Angelova A., Deng Y., Tremblay M.-&#xc8;. Chronic Inflammation, Neuroglial Dysfunction, and Plasmalogen Deficiency as a New Pathobiological Hypothesis Addressing the Overlap between Post-COVID-19 Symptoms and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Brain Res. Bull. 2023;201:110702. doi: 10.1016/j.brainresbull.2023.110702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2023.110702</ArticleId><ArticleId IdType="pubmed">37423295</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. Insights from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome May Help Unravel the Pathogenesis of Postacute COVID-19 Syndrome. Trends Mol. Med. 2021;27:895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B.D., Lemle M.D., Komaroff A.L., Snyder S.H. Redox Imbalance Links COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Proc. Natl. Acad. Sci. USA. 2021;118:e2024358118. doi: 10.1073/pnas.2024358118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Toogood P.L., Clauw D.J., Phadke S., Hoffman D. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Where Will the Drugs Come From? Pharmacol. Res. 2021;165:105465. doi: 10.1016/j.phrs.2021.105465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105465</ArticleId><ArticleId IdType="pubmed">33529750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamanian M., Hajizadeh M., Shamsizadeh A., Moemenzadeh M., Amirteimouri M., Elshiekh M., Allahtavakoli M. Effects of Naringin on Physical Fatigue and Serum MMP-9 Concentration in Female Rats. Pharm. Biol. 2016;55:423&#x2013;427. doi: 10.1080/13880209.2016.1244553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13880209.2016.1244553</ArticleId><ArticleId IdType="pmc">PMC6130689</ArticleId><ArticleId IdType="pubmed">27937032</ArticleId></ArticleIdList></Reference><Reference><Citation>Balachandran A., Choi S.B., Beata M.-M., Ma&#x142;gorzata J., Froemming G.R.A., Lavilla C.A., Billacura M.P., Siyumbwa S.N., Okechukwu P.N. Antioxidant, Wound Healing Potential and in Silico Assessment of Naringin, Eicosane and Octacosane. Molecules. 2023;28:1043. doi: 10.3390/molecules28031043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules28031043</ArticleId><ArticleId IdType="pmc">PMC9919607</ArticleId><ArticleId IdType="pubmed">36770709</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Deng S., Li J., Gong S., Song T., Ge J., Zhao Y., Zhang J., Ma L., Zheng Y., et al. UPLC-MS Analysis and Network Pharmacology-Based Investigation into the Active Ingredients and Molecular Mechanisms of Anti-Fatigue of Male Flowers with Eucommia Ulmoides Oliv. Fundam. Clin. Pharmacol. 2022;36:1083&#x2013;1098. doi: 10.1111/fcp.12798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/fcp.12798</ArticleId><ArticleId IdType="pubmed">35535756</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulasekaran G., Ganapasam S. Neuroprotective Efficacy of Naringin on 3-Nitropropionic Acid-Induced Mitochondrial Dysfunction through the Modulation of Nrf2 Signaling Pathway in PC12 Cells. Mol. Cell. Biochem. 2015;409:199&#x2013;211. doi: 10.1007/s11010-015-2525-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-015-2525-9</ArticleId><ArticleId IdType="pubmed">26280522</ArticleId></ArticleIdList></Reference><Reference><Citation>Varshney V., Garabadu D. Naringin Exhibits Mas Receptor&#x2013;Mediated Neuroprotection against Amyloid Beta&#x2013;Induced Cognitive Deficits and Mitochondrial Toxicity in Rat Brain. Neurotox. Res. 2021;39:1023&#x2013;1043. doi: 10.1007/s12640-021-00336-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-021-00336-y</ArticleId><ArticleId IdType="pubmed">33534126</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Chen Z., Huang L., Meng B., Zhou X., Wen X., Ren D. Naringenin Reduces Oxidative Stress and Improves Mitochondrial Dysfunction via Activation of the Nrf2/ARE Signaling Pathway in Neurons. Int. J. Mol. Med. 2017;40:1582&#x2013;1590. doi: 10.3892/ijmm.2017.3134.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2017.3134</ArticleId><ArticleId IdType="pubmed">28949376</ArticleId></ArticleIdList></Reference><Reference><Citation>Vij G., Gupta A., Chopra K. Modulation of Antigen-Induced Chronic Fatigue in Mouse Model of Water Immersion Stress by Naringin, a Polyphenolic Antioxidant. Fundam. Clin. Pharmacol. 2009;23:331&#x2013;337. doi: 10.1111/j.1472-8206.2009.00675.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1472-8206.2009.00675.x</ArticleId><ArticleId IdType="pubmed">19469804</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanatha G.L., Shylaja H., Moolemath Y. The Beneficial Role of Naringin- a Citrus Bioflavonoid, against Oxidative Stress-Induced Neurobehavioral Disorders and Cognitive Dysfunction in Rodents: A Systematic Review and Meta-Analysis. Biomed. Pharmacother. 2017;94:909&#x2013;929. doi: 10.1016/j.biopha.2017.07.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.07.072</ArticleId><ArticleId IdType="pubmed">28810519</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-Term Cardiovascular Outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Huseynov A., Akin I., Duerschmied D., Scharf R.E. Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment. Viruses. 2023;15:389. doi: 10.3390/v15020389.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020389</ArticleId><ArticleId IdType="pmc">PMC9959721</ArticleId><ArticleId IdType="pubmed">36851603</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo B., Zhao C., He M.Z., Senter C., Zhou Z., Peng J., Li S., Fitzpatrick A.L., Lindstr&#xf6;m S., Stebbins R.C., et al. Identifying Patterns of Reported Findings on Long-Term Cardiac Complications of COVID-19: A Systematic Review and Meta-Analysis. BMC Med. 2023;21:468. doi: 10.1186/s12916-023-03162-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-03162-5</ArticleId><ArticleId IdType="pmc">PMC10685580</ArticleId><ArticleId IdType="pubmed">38017426</ArticleId></ArticleIdList></Reference><Reference><Citation>Szarpak L., Pruc M., Filipiak K.J., Popieluch J., Bielski A., Jaguszewski M.J., Gilis-Malinowska N., Chirico F., Afique Z.R., Peacock F.W. Myocarditis: A Complication of COVID-19 and Long-COVID-19 Syndrome as a Serious Threat in Modern Cardiology. Cardiol. J. 2022;29:178&#x2013;179. doi: 10.5603/CJ.a2021.0155.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2021.0155</ArticleId><ArticleId IdType="pmc">PMC8890406</ArticleId><ArticleId IdType="pubmed">34811716</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M., Rigatelli G., Bilato C., Porcari A., Merlo M., Roncon L., Sinagra G. One-Year Risk of Myocarditis after COVID-19 Infection: A Systematic Review and Meta-Analysis. Can. J. Cardiol. 2023;39:839&#x2013;844. doi: 10.1016/j.cjca.2022.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2022.12.003</ArticleId><ArticleId IdType="pmc">PMC9743686</ArticleId><ArticleId IdType="pubmed">36521730</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar Y., Sandhyavenu H., Patel N., Victor V., Patel D., Hussain B., Titus A., Thyagaturu H., Alraiyes M., Atti L., et al. In-Hospital Outcomes of COVID-19 Associated Myocarditis (from a Nationwide Inpatient Sample Database Study) Am. J. Cardiol. 2023;192:39&#x2013;44. doi: 10.1016/j.amjcard.2023.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2023.01.004</ArticleId><ArticleId IdType="pmc">PMC9884177</ArticleId><ArticleId IdType="pubmed">36716522</ArticleId></ArticleIdList></Reference><Reference><Citation>Okor I., Bob-Manuel T., Price J., Sleem A., Amoran O., Kelly J., Ekerete M.F., Bamgbose M.O., Bolaji O.A., Krim S.R. COVID-19 Myocarditis: An Emerging Clinical Conundrum. Curr. Probl. Cardiol. 2022;47:101268. doi: 10.1016/j.cpcardiol.2022.101268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2022.101268</ArticleId><ArticleId IdType="pmc">PMC9135640</ArticleId><ArticleId IdType="pubmed">35644500</ArticleId></ArticleIdList></Reference><Reference><Citation>Elseidy S.A., Awad A.K., Vorla M., Fatima A., Elbadawy M.A., Mandal D., Mohamad T. Cardiovascular Complications in the Post-Acute COVID-19 Syndrome (Pacs) Int. J. Cardiol. Heart Vasc. 2022;40:101012. doi: 10.1016/j.ijcha.2022.101012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2022.101012</ArticleId><ArticleId IdType="pmc">PMC8958273</ArticleId><ArticleId IdType="pubmed">35355927</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva L.S., Boldrini V.O., Marques A.M., Yasuda C.L. Post-COVID Myocarditis with Antiheart Antibodies Persistence: Clues for Autoimmunity? Clin. Cardiol. 2023;46:350&#x2013;351. doi: 10.1002/clc.23979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23979</ArticleId><ArticleId IdType="pmc">PMC10018105</ArticleId><ArticleId IdType="pubmed">36691992</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang X., Ismail N.I., Rahman A., Xu D., Chan R.W.Y., Ong S.-G., Ong S.-B. Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link? Antioxid. Redox Signal. 2023;38:599&#x2013;618. doi: 10.1089/ars.2022.0126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2022.0126</ArticleId><ArticleId IdType="pmc">PMC10025846</ArticleId><ArticleId IdType="pubmed">36053670</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeem A., Tabassum S., Gill S., Khan M.Z., Mumtaz N., Qaiser Q., Karamat M., Arif M., Naeem F., Afifi A., et al. COVID-19 and Cardiovascular Diseases: A Literature Review from Pathogenesis to Diagnosis. Cureus. 2023;15:e35658. doi: 10.7759/cureus.35658.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.35658</ArticleId><ArticleId IdType="pmc">PMC10065369</ArticleId><ArticleId IdType="pubmed">37009373</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L.-J., Qiao W., Xiao Y.-J., Cui L., Wang X., Ren W.-D. Naringin Mitigates Myocardial Strain and the Inflammatory Response in Sepsis-Induced Myocardial Dysfunction through Regulation of PI3K/AKT/NF-&#x3ba;B Pathway. Int. Immunopharmacol. 2019;75:105782. doi: 10.1016/j.intimp.2019.105782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2019.105782</ArticleId><ArticleId IdType="pubmed">31376623</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S.-H., Ma G.-L., Zhang S.-L., Yang Y.-Y., Liu H.-F., Luo A., Wen J., Cao Z.-Z., Jia Y.-Z. Naringin Exerts Antiarrhythmic Effects by Inhibiting Channel Currents in Mouse Cardiomyocytes. J. Electrocardiol. 2023;80:69&#x2013;80. doi: 10.1016/j.jelectrocard.2023.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2023.05.003</ArticleId><ArticleId IdType="pubmed">37262953</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart I., Jacob J., George P.M., Molyneaux P.L., Porter J.C., Allen R.J., Aslani S., Baillie J.K., Barratt S.L., Beirne P., et al. Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post&#x2013;COVID-19 Study. Am. J. Respir. Crit. Care Med. 2023;207:693&#x2013;703. doi: 10.1164/rccm.202203-0564OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202203-0564OC</ArticleId><ArticleId IdType="pmc">PMC10037479</ArticleId><ArticleId IdType="pubmed">36457159</ArticleId></ArticleIdList></Reference><Reference><Citation>Farghaly S., Badedi M., Ibrahim R., Sadhan M.H., Alamoudi A., Alnami A., Muhajir A. Clinical Characteristics and Outcomes of Post-COVID-19 Pulmonary Fibrosis. Medicine. 2022;101:e28639. doi: 10.1097/MD.0000000000028639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000028639</ArticleId><ArticleId IdType="pmc">PMC8772621</ArticleId><ArticleId IdType="pubmed">35060549</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;n E., Yang C., Shannon C.P., Assadian S., He D., Tebbutt S.J. Cellular and Molecular Biomarkers of Long COVID: A Scoping Review. EBioMedicine. 2023;91:104552. doi: 10.1016/j.ebiom.2023.104552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104552</ArticleId><ArticleId IdType="pmc">PMC10082390</ArticleId><ArticleId IdType="pubmed">37037165</ArticleId></ArticleIdList></Reference><Reference><Citation>Hama Amin B.J., Kakamad F.H., Ahmed G.S., Ahmed S.F., Abdulla B.A., Mohammed S.H., Mikael T.M., Salih R.Q., Ali R.k., Salh A.M., et al. Post COVID-19 Pulmonary Fibrosis; a Meta-Analysis Study. Ann. Med. Surg. 2022;77:103590. doi: 10.1016/j.amsu.2022.103590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.103590</ArticleId><ArticleId IdType="pmc">PMC8983072</ArticleId><ArticleId IdType="pubmed">35411216</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirawat R., Jain N., Aslam Saifi M., Rachamalla M., Godugu C. Lung Fibrosis: Post-COVID-19 Complications and Evidences. Int. Immunopharmacol. 2023;116:109418. doi: 10.1016/j.intimp.2022.109418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.109418</ArticleId><ArticleId IdType="pmc">PMC9633631</ArticleId><ArticleId IdType="pubmed">36736220</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrucco F., Solidoro P., Gavelli F., Apostolo D., Bellan M. Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks. Microorganisms. 2023;11:895. doi: 10.3390/microorganisms11040895.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11040895</ArticleId><ArticleId IdType="pmc">PMC10146995</ArticleId><ArticleId IdType="pubmed">37110318</ArticleId></ArticleIdList></Reference><Reference><Citation>George P.M., Wells A.U., Jenkins R.G. Pulmonary Fibrosis and COVID-19: The Potential Role for Antifibrotic Therapy. Lancet Respir. Med. 2020;8:807&#x2013;815. doi: 10.1016/S2213-2600(20)30225-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30225-3</ArticleId><ArticleId IdType="pmc">PMC7228727</ArticleId><ArticleId IdType="pubmed">32422178</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Wu G., Dai T., Lang Y., Chi Z., Yang S., Dong D. Naringin Attenuates Renal Interstitial Fibrosis by Regulating the TGF-&#x3b2;/Smad Signaling Pathway and Inflammation. Exp. Ther. Med. 2021;21:66. doi: 10.3892/etm.2020.9498.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2020.9498</ArticleId><ArticleId IdType="pmc">PMC7716641</ArticleId><ArticleId IdType="pubmed">33365066</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Li W., Hu H., Lu X., Qin S. Monomeric Compounds from Traditional Chinese Medicine: New Hopes for Drug Discovery in Pulmonary Fibrosis. Biomed. Pharmacother. 2023;159:114226. doi: 10.1016/j.biopha.2023.114226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.114226</ArticleId><ArticleId IdType="pubmed">36657302</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Zhou X., Zhong Y., Ji L., Yu W., Fang J., Ying H., Li C. Naringin Suppressed Airway Inflammation and Ameliorated Pulmonary Endothelial Hyperpermeability by Upregulating Aquaporin1 in Lipopolysaccharide/Cigarette Smoke-Induced Mice. Biomed. Pharmacother. 2022;150:113035. doi: 10.1016/j.biopha.2022.113035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113035</ArticleId><ArticleId IdType="pubmed">35658207</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Nie Y., Luo Y., Lin F., Zheng Y., Cheng G., Wu H., Zhang K., Su W., Shen J., et al. Protective Effects of Naringin against Paraquat-Induced Acute Lung Injury and Pulmonary Fibrosis in Mice. Food Chem. Toxicol. 2013;58:133&#x2013;140. doi: 10.1016/j.fct.2013.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2013.04.024</ArticleId><ArticleId IdType="pubmed">23603004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y., Sun L., Liu C., Li L. Naringin Regulates Endoplasmic Reticulum Stress and Mitophagy through the ATF3/PINK1 Signaling Axis to Alleviate Pulmonary Fibrosis. Naunyn. Schmiedebergs Arch. Pharmacol. 2023;396:1155&#x2013;1169. doi: 10.1007/s00210-023-02390-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-023-02390-z</ArticleId><ArticleId IdType="pubmed">36688958</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W., Xu Z., Zhang J., Guan M., Zheng Y., Wang Y., Wu H., Su W., Li P. Naringenin Regulates Cigarette Smoke Extract-Induced Extracellular Vesicles from Alveolar Macrophage to Attenuate the Mouse Lung Epithelial Ferroptosis through Activating EV miR-23a-3p/ACSL4 Axis. Phytomedicine. 2024;124:155256. doi: 10.1016/j.phymed.2023.155256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2023.155256</ArticleId><ArticleId IdType="pubmed">38181527</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud N., Radwan N., Alkattan A., Hassanien M., Elkajam E., Alqahtani S., Haji A., Alfaifi A., Alfaleh A., Alabdulkareem K. Post-COVID-19 Syndrome: Nature of Symptoms and Associated Factors. Z. Cesundh. Wiss. 2023;32:207&#x2013;212. doi: 10.1007/s10389-022-01802-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10389-022-01802-3</ArticleId><ArticleId IdType="pmc">PMC9809515</ArticleId><ArticleId IdType="pubmed">36619479</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M., Babicki M., Kapusta J., Ka&#x142;uzi&#x144;ska-Ko&#x142;at &#x17b;., Ko&#x142;at D., Jankowski P., Mastalerz-Migas A. Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the poLoCOV Study. Viruses. 2022;14:1755. doi: 10.3390/v14081755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081755</ArticleId><ArticleId IdType="pmc">PMC9415629</ArticleId><ArticleId IdType="pubmed">36016376</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Guijarro C., Plaza-Canteli S., Hern&#xe1;ndez-Barrera V., Torres-Macho J. Prevalence of Post-COVID-19 Cough One Year after SARS-CoV-2 Infection: A Multicenter Study. Lung. 2021;199:249&#x2013;253. doi: 10.1007/s00408-021-00450-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00450-w</ArticleId><ArticleId IdType="pmc">PMC8124095</ArticleId><ArticleId IdType="pubmed">33993321</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W.-J., Hui C.K.M., Hull J.H., Birring S.S., McGarvey L., Mazzone S.B., Chung K.F. Confronting COVID-19-Associated Cough and the Post-COVID Syndrome: Role of Viral Neurotropism, Neuroinflammation, and Neuroimmune Responses. Lancet Respir. Med. 2021;9:533&#x2013;544. doi: 10.1016/S2213-2600(21)00125-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00125-9</ArticleId><ArticleId IdType="pmc">PMC8041436</ArticleId><ArticleId IdType="pubmed">33857435</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen-Ho L., Nguyen-Nhu V., Tran-Thi T.-T., Solomon J.J. Severe Chronic Cough Relating to Post-COVID-19 Interstitial Lung Disease: A Case Report. Asia Pac. Allergy. 2022;12:e42. doi: 10.5415/apallergy.2022.12.e42.</Citation><ArticleIdList><ArticleId IdType="doi">10.5415/apallergy.2022.12.e42</ArticleId><ArticleId IdType="pmc">PMC9669464</ArticleId><ArticleId IdType="pubmed">36452019</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouadi P.W., Idriss S.A., Bousquet J., Laidlaw T.M., Azar C.R., Al-Ahmad M.S., Ya&#xf1;ez A., Al-Nesf M.A.Y., Nsouli T.M., Bahna S.L., et al. WAO-ARIA Consensus on Chronic Cough&#x2014;Part II: Phenotypes and Mechanisms of Abnormal Cough Presentation&#x2014;Updates in COVID-19. World Allergy Organ. J. 2021;14:100618. doi: 10.1016/j.waojou.2021.100618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.waojou.2021.100618</ArticleId><ArticleId IdType="pmc">PMC8666560</ArticleId><ArticleId IdType="pubmed">34963794</ArticleId></ArticleIdList></Reference><Reference><Citation>Gencer A., Caliskaner Ozturk B., Borekci S., Gemicioglu B. Bronchodilator Reversibility Testing in Long-Term Cough and Dyspnea after COVID-19 Viral Infection: A Trigger for Asthma? J. Asthma Off. J. Assoc. Care Asthma. 2023;60:1221&#x2013;1226. doi: 10.1080/02770903.2022.2139719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770903.2022.2139719</ArticleId><ArticleId IdType="pubmed">36279253</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai D.K., Sharma P., Karmakar S., Thakur S., Ameet H., Yadav R., Gupta V.B. Approach to Post COVID-19 Persistent Cough: A Narrative Review. Lung India. 2023;40:149&#x2013;154. doi: 10.4103/lungindia.lungindia_250_22.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/lungindia.lungindia_250_22</ArticleId><ArticleId IdType="pmc">PMC10174656</ArticleId><ArticleId IdType="pubmed">37006099</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanasi A., Fontana G.A., Mutolo D. Cough: Pathophysiology, Diagnosis and Treatment. 1st ed. Springer International Publishing; Cham, Switzerland: 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-48571-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta G., Almalki W.H., Kazmi I., Fuloria N.K., Fuloria S., Subramaniyan V., Sekar M., Singh S.K., Chellappan D.K., Dua K. Current Update on the Protective Effect of Naringin in Inflammatory Lung Diseases. EXCLI J. 2022;21:573&#x2013;579. doi: 10.17179/excli2022-4752.</Citation><ArticleIdList><ArticleId IdType="doi">10.17179/excli2022-4752</ArticleId><ArticleId IdType="pmc">PMC9203983</ArticleId><ArticleId IdType="pubmed">35721579</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Yao J., Zhang J. Naringenin Attenuates Inflammation in Chronic Obstructive Pulmonary Disease in Cigarette Smoke Induced Mouse Model and Involves Suppression of NF-&#x3ba;B. J. Microbiol. Biotechnol. 2018 doi: 10.4014/jmb.1810.10061.</Citation><ArticleIdList><ArticleId IdType="doi">10.4014/jmb.1810.10061</ArticleId><ArticleId IdType="pubmed">30609878</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao H., Su W., Li P., Liao Y., Zhou Q., Zhu N., He L. Therapeutic Effects of Naringin in a Guinea Pig Model of Ovalbumin-Induced Cough-Variant Asthma. Pulm. Pharmacol. Ther. 2015;33:59&#x2013;65. doi: 10.1016/j.pupt.2015.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pupt.2015.07.002</ArticleId><ArticleId IdType="pubmed">26169899</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y., Li P., Zhang C., Zheng Y., Wang S., Nie Y., Zhang K., Su W. Effects of Four Antitussives on Airway Neurogenic Inflammation in a Guinea Pig Model of Chronic Cough Induced by Cigarette Smoke Exposure. Inflamm. Res. 2013;62:1053&#x2013;1061. doi: 10.1007/s00011-013-0664-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-013-0664-6</ArticleId><ArticleId IdType="pubmed">24085318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni K., Guo J., Bu B., Pan Y., Li J., Liu L., Luo M., Deng L. Naringin as a Plant-Derived Bitter Tastant Promotes Proliferation of Cultured Human Airway Epithelial Cells via Activation of TAS2R Signaling. Phytomedicine. 2021;84:153491. doi: 10.1016/j.phymed.2021.153491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2021.153491</ArticleId><ArticleId IdType="pubmed">33601237</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K., Valabhji J., Misra S. Diabetes and the COVID-19 Pandemic. Diabetologia. 2023;66:255&#x2013;266. doi: 10.1007/s00125-022-05833-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-022-05833-z</ArticleId><ArticleId IdType="pmc">PMC9685151</ArticleId><ArticleId IdType="pubmed">36418578</ArticleId></ArticleIdList></Reference><Reference><Citation>Suwanwongse K., Shabarek N. Newly Diagnosed Diabetes Mellitus, DKA, and COVID-19: Causality or Coincidence? A Report of Three Cases. J. Med. Virol. 2021;93:1150&#x2013;1153. doi: 10.1002/jmv.26339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26339</ArticleId><ArticleId IdType="pmc">PMC7404645</ArticleId><ArticleId IdType="pubmed">32706395</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssentongo P., Zhang Y., Witmer L., Chinchilli V.M., Ba D.M. Association of COVID-19 with Diabetes: A Systematic Review and Meta-Analysis. Sci. Rep. 2022;12:20191. doi: 10.1038/s41598-022-24185-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-24185-7</ArticleId><ArticleId IdType="pmc">PMC9684130</ArticleId><ArticleId IdType="pubmed">36418912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Mei Q., Zhang Z., Walline J.H., Liu Y., Zhu H., Zhang S. Risk for Newly Diagnosed Diabetes after COVID-19: A Systematic Review and Meta-Analysis. BMC Med. 2022;20:444. doi: 10.1186/s12916-022-02656-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02656-y</ArticleId><ArticleId IdType="pmc">PMC9666960</ArticleId><ArticleId IdType="pubmed">36380329</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M., Keshvari M., Mirnasuri S., Yon D.K., Lee S.W., Il Shin J., Smith L. The Global Impact of COVID-19 Pandemic on the Incidence of Pediatric New-onset Type 1 Diabetes and Ketoacidosis: A Systematic Review and Meta-analysis. J. Med. Virol. 2022;94:5112&#x2013;5127. doi: 10.1002/jmv.27996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27996</ArticleId><ArticleId IdType="pmc">PMC9350204</ArticleId><ArticleId IdType="pubmed">35831242</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J.Y., Wilson J., Hou W., Fleysher R., Herold B.C., Herold K.C., Duong T.Q. Incidence of New-Onset in-Hospital and Persistent Diabetes in COVID-19 Patients: Comparison with Influenza. EBioMedicine. 2023;90:104487. doi: 10.1016/j.ebiom.2023.104487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104487</ArticleId><ArticleId IdType="pmc">PMC9970376</ArticleId><ArticleId IdType="pubmed">36857969</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurenzi A., Caretto A., Molinari C., Mercalli A., Melzi R., Nano R., Tresoldi C., Rovere Querini P., Ciceri F., Lampasona V., et al. No Evidence of Long-Term Disruption of Glycometabolic Control after SARS-CoV-2 Infection. J. Clin. Endocrinol. Metab. 2021;107:e1009&#x2013;e1019. doi: 10.1210/clinem/dgab792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab792</ArticleId><ArticleId IdType="pmc">PMC8691144</ArticleId><ArticleId IdType="pubmed">34718627</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao H., Baranova A., Wei X., Wang C., Zhang F. Bidirectional Causal Associations between Type 2 Diabetes and COVID-19. J. Med. Virol. 2023;95:e28100. doi: 10.1002/jmv.28100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28100</ArticleId><ArticleId IdType="pmc">PMC9538258</ArticleId><ArticleId IdType="pubmed">36029131</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L., Ben Nasr M., D&#x2019;Addio F., Loretelli C., Rossi A., Pastore I., Daniele G., Abdelsalam A., Maestroni A., Dell&#x2019;Acqua M., et al. Acute and Long-Term Disruption of Glycometabolic Control after SARS-CoV-2 Infection. Nat. Metab. 2021;3:774&#x2013;785. doi: 10.1038/s42255-021-00407-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Fotea S., Ghiciuc C.M., Stefanescu G., Cianga A.L., Mihai C.M., Lupu A., Butnariu L.I., Starcea I.M., Salaru D.L., Mocanu A., et al. Pediatric COVID-19 and Diabetes: An Investigation into the Intersection of Two Pandemics. Diagnostics. 2023;13:2436. doi: 10.3390/diagnostics13142436.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13142436</ArticleId><ArticleId IdType="pmc">PMC10378192</ArticleId><ArticleId IdType="pubmed">37510181</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Long X., Zhang B., Zhang W., Chen X., Zhang Z. ACE2 Expression in Pancreas May Cause Pancreatic Damage after SARS-CoV-2 Infection. Clin. Gastroenterol. Hepatol. 2020;18:2128&#x2013;2130. doi: 10.1016/j.cgh.2020.04.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.04.040</ArticleId><ArticleId IdType="pmc">PMC7194639</ArticleId><ArticleId IdType="pubmed">32334082</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusmartseva I., Wu W., Syed F., Van Der Heide V., Jorgensen M., Joseph P., Tang X., Candelario-Jalil E., Yang C., Nick H., et al. Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19. Cell Metab. 2020;32:1041&#x2013;1051. doi: 10.1016/j.cmet.2020.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.11.005</ArticleId><ArticleId IdType="pmc">PMC7664515</ArticleId><ArticleId IdType="pubmed">33207244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden M.R. An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of &#x3b2;-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms. Cells. 2020;9:2475. doi: 10.3390/cells9112475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9112475</ArticleId><ArticleId IdType="pmc">PMC7697826</ArticleId><ArticleId IdType="pubmed">33202960</ArticleId></ArticleIdList></Reference><Reference><Citation>Birabaharan M., Kaelber D.C., Pettus J.H., Smith D.M. Risk of New-Onset Type 2 Diabetes Mellitus in 600,055 Persons after COVID-19: A Cohort Study. Diabetes Obes. Metab. 2022;24:1176&#x2013;1179. doi: 10.1111/dom.14659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14659</ArticleId><ArticleId IdType="pmc">PMC9035030</ArticleId><ArticleId IdType="pubmed">35112782</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao T., Ding J., Liang Z., Cui X., He K., Chen L., Li J. When Type II Diabetes Mellitus Meets COVID-19&#x2014;Identification of the Shared Gene Signatures and Biological Mechanism between the Two Diseases. Eur. J. Clin. Investig. 2023;53:e13955. doi: 10.1111/eci.13955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13955</ArticleId><ArticleId IdType="pubmed">36656083</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajappa R., Sireesh D., Salai M.B., Ramkumar K.M., Sarvajayakesavulu S., Madhunapantula S.V. Treatment with Naringenin Elevates the Activity of Transcription Factor Nrf2 to Protect Pancreatic &#x3b2;-Cells from Streptozotocin-Induced Diabetes in Vitro and in Vivo. Front. Pharmacol. 2018;9:1562. doi: 10.3389/fphar.2018.01562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.01562</ArticleId><ArticleId IdType="pmc">PMC6360183</ArticleId><ArticleId IdType="pubmed">30745874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim Y.J., Kim J.H., Pan J.H., Kim J.K., Park T.-S., Kim Y.J., Lee J.H., Kim J.H. Naringin Protects Pancreatic &#x3b2;-Cells against Oxidative Stress-Induced Apoptosis by Inhibiting Both Intrinsic and Extrinsic Pathways in Insulin-Deficient Diabetic Mice. Mol. Nutr. Food Res. 2018;62:1700810. doi: 10.1002/mnfr.201700810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201700810</ArticleId><ArticleId IdType="pubmed">29314619</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian M., Thotakura B., Chandra Sekaran S.P., Jyothi A.K., Sundaramurthi I. Naringin Ameliorates Streptozotocin-Induced Diabetes through Forkhead Box M1-Mediated Beta Cell Proliferation. Cells Tissues Organs. 2019;206:242&#x2013;253. doi: 10.1159/000499480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000499480</ArticleId><ArticleId IdType="pubmed">31067533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed O.M., Hassan M.A., Abdel-Twab S.M., Abdel Azeem M.N. Navel Orange Peel Hydroethanolic Extract, Naringin and Naringenin Have Anti-Diabetic Potentials in Type 2 Diabetic Rats. Biomed. Pharmacother. 2017;94:197&#x2013;205. doi: 10.1016/j.biopha.2017.07.094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.07.094</ArticleId><ArticleId IdType="pubmed">28759757</ArticleId></ArticleIdList></Reference><Reference><Citation>Murunga A.N., Miruka D.O., Driver C., Nkomo F.S., Cobongela S.Z.Z., Owira P.M.O. Grapefruit Derived Flavonoid Naringin Improves Ketoacidosis and Lipid Peroxidation in Type 1 Diabetes Rat Model. PLoS ONE. 2016;11:e0153241. doi: 10.1371/journal.pone.0153241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0153241</ArticleId><ArticleId IdType="pmc">PMC4830547</ArticleId><ArticleId IdType="pubmed">27073901</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud A.M., Ahmed O.M., Ashour M.B., Abdel-Moneim A. In Vivo and in Vitro Antidiabetic Effects of Citrus Flavonoids; a Study on the Mechanism of Action. Int. J. Diabetes Dev. Ctries. 2015;35:250&#x2013;263. doi: 10.1007/s13410-014-0268-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13410-014-0268-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida H., Watanabe H., Ishida A., Watanabe W., Narumi K., Atsumi T., Sugita C., Kurokawa M. Naringenin Suppresses Macrophage Infiltration into Adipose Tissue in an Early Phase of High-Fat Diet-Induced Obesity. Biochem. Biophys. Res. Commun. 2014;454:95&#x2013;101. doi: 10.1016/j.bbrc.2014.10.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.10.038</ArticleId><ArticleId IdType="pubmed">25450363</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P., Bansal S., Kuhad A., Kumar A., Chopra K. Naringenin Ameliorates Diabetic Neuropathic Pain by Modulation of Oxidative-Nitrosative Stress, Cytokines and MMP-9 Levels. Food Funct. 2020;11:4548&#x2013;4560. doi: 10.1039/C9FO00881K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9FO00881K</ArticleId><ArticleId IdType="pubmed">32400767</ArticleId></ArticleIdList></Reference><Reference><Citation>He W., Wang Y., Yang R., Ma H., Qin X., Yan M., Rong Y., Xie Y., Li L., Si J., et al. Molecular Mechanism of Naringenin against High-Glucose-Induced Vascular Smooth Muscle Cells Proliferation and Migration Based on Network Pharmacology and Transcriptomic Analyses. Front. Pharmacol. 2022;13:862709. doi: 10.3389/fphar.2022.862709.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.862709</ArticleId><ArticleId IdType="pmc">PMC9219407</ArticleId><ArticleId IdType="pubmed">35754483</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiala K., Martens J., Abd-Elsayed A. Post-COVID Pain Syndromes. Curr. Pain Headache Rep. 2022;26:379&#x2013;383. doi: 10.1007/s11916-022-01038-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-022-01038-6</ArticleId><ArticleId IdType="pmc">PMC8907389</ArticleId><ArticleId IdType="pubmed">35267156</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel K., Pinto C., Jaiswal R., Tirupathi R., Pillai S., Patel U. Post-acute COVID-19 Syndrome (PCS) and Health-related Quality of Life (HRQoL)&#x2014;A Systematic Review and Meta-analysis. J. Med. Virol. 2022;94:253&#x2013;262. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Navarro-Santana M., Plaza-Manzano G., Palacios-Ce&#xf1;a D., Arendt-Nielsen L. Time Course Prevalence of Post-COVID Pain Symptoms of Musculoskeletal Origin in Patients Who Had Survived Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic Review and Meta-Analysis. Pain. 2022;163:1220. doi: 10.1097/j.pain.0000000000002496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002496</ArticleId><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A., Shetty A., Delanerolle G., Zeng Y., Zhang Y., Raymont V., Rathod S., Halabi S., Elliot K., Shi J.Q., et al. A Systematic Review and Meta-Analysis of Long COVID Symptoms. Syst. Rev. 2023;12:88. doi: 10.1186/s13643-023-02250-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-023-02250-0</ArticleId><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Xu X., Chen Z., Duan J., Hashimoto K., Yang L., Liu C., Yang C. Nervous System Involvement after Infection with COVID-19 and Other Coronaviruses. Brain Behav. Immun. 2020;87:18&#x2013;22. doi: 10.1016/j.bbi.2020.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussmann A.J.C., Ferraz C.R., Lima A.V.A., Castro J.G.S., Ritter P.D., Zaninelli T.H., Saraiva-Santos T., Verri W.A., Borghi S.M. Association between IL-10 Systemic Low Level and Highest Pain Score in Patients during Symptomatic SARS-CoV-2 Infection. Pain Pract. Pain. 2022;22:453&#x2013;462. doi: 10.1111/papr.13101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/papr.13101</ArticleId><ArticleId IdType="pubmed">35080097</ArticleId></ArticleIdList></Reference><Reference><Citation>Rani M., Uniyal A., Akhilesh, Tiwari V. Decrypting the Cellular and Molecular Intricacies Associated with COVID-19-Induced Chronic Pain. Metab. Brain Dis. 2022;37:2629&#x2013;2642. doi: 10.1007/s11011-022-01048-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-022-01048-8</ArticleId><ArticleId IdType="pmc">PMC9289353</ArticleId><ArticleId IdType="pubmed">35849300</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeshita H., Yamamoto K. Tryptophan Metabolism and COVID-19-Induced Skeletal Muscle Damage: Is ACE2 a Key Regulator? Front. Nutr. 2022;9:868845. doi: 10.3389/fnut.2022.868845.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.868845</ArticleId><ArticleId IdType="pmc">PMC9028463</ArticleId><ArticleId IdType="pubmed">35463998</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C., Bentivegna E., Cho S.-J., Harriott A.M., Garc&#xed;a-Azor&#xed;n D., Labastida-Ramirez A., Ornello R., Raffaelli B., Beltr&#xe1;n E.R., Ruscheweyh R., et al. Long COVID Headache. J. Headache Pain. 2022;23:93. doi: 10.1186/s10194-022-01450-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolay H., Karadas &#xd6;., Ozt&#xfc;rk B., Sonkaya R., Tasdelen B., Bulut T.D.S., G&#xfc;lbahar &#xd6;., &#xd6;zge A., Baykan B. HMGB1, NLRP3, IL-6 and ACE2 Levels Are Elevated in COVID-19 with Headache: A Window to the Infection-Related Headache Mechanism. J. Headache Pain. 2021;22:94. doi: 10.1186/s10194-021-01306-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-021-01306-7</ArticleId><ArticleId IdType="pmc">PMC8358545</ArticleId><ArticleId IdType="pubmed">34384355</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E., Ballv&#xe9; A., Llaurad&#xf3; A., Gallardo V.J., Ariton D.M., Lallana S., L&#xf3;pez Maza S., Oliv&#xe9; Gadea M., Quibus L., Restrepo J.L., et al. Headache: A Striking Prodromal and Persistent Symptom, Predictive of COVID-19 Clinical Evolution. Cephalalgia. 2020;40:1410&#x2013;1421. doi: 10.1177/0333102420965157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965157</ArticleId><ArticleId IdType="pmc">PMC7645597</ArticleId><ArticleId IdType="pubmed">33146036</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q., Zhang Z., Sun W. Effect of Naringin on Monosodium Iodoacetate-Induced Osteoarthritis Pain in Rats. Med. Sci. Monit. 2017;23:3746&#x2013;3751. doi: 10.12659/MSM.902396.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.902396</ArticleId><ArticleId IdType="pmc">PMC5551934</ArticleId><ArticleId IdType="pubmed">28765519</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C., Zhao Y.-T. Analgesic Effects of Naringenin in Rats with Spinal Nerve Ligation-Induced Neuropathic Pain. Biomed. Rep. 2014;2:569&#x2013;573. doi: 10.3892/br.2014.267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2014.267</ArticleId><ArticleId IdType="pmc">PMC4051469</ArticleId><ArticleId IdType="pubmed">24944810</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghazadeh Tabrizi M., Baraldi P.G., Baraldi S., Gessi S., Merighi S., Borea P.A. Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists. Med. Res. Rev. 2017;37:936&#x2013;983. doi: 10.1002/med.21427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21427</ArticleId><ArticleId IdType="pubmed">27976413</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz B., Zaguri R., Edvardson S., Maayan C., Elpeleg O., Lev S., Davidson E., Peters M., Kfir-Erenfeld S., Berger E., et al. Nociception and Pain in Humans Lacking a Functional TRPV1 Channel. J. Clin. Investig. 2023;133:e153558. doi: 10.1172/JCI153558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI153558</ArticleId><ArticleId IdType="pmc">PMC9888381</ArticleId><ArticleId IdType="pubmed">36454632</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouin O., L&#x2019;Herondelle K., Lebonvallet N., Le Gall-Ianotto C., Sakka M., Buh&#xe9; V., Pl&#xe9;e-Gautier E., Carr&#xe9; J.-L., Lefeuvre L., Misery L., et al. TRPV1 and TRPA1 in Cutaneous Neurogenic and Chronic Inflammation: Pro-Inflammatory Response Induced by Their Activation and Their Sensitization. Protein Cell. 2017;8:644&#x2013;661. doi: 10.1007/s13238-017-0395-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-017-0395-5</ArticleId><ArticleId IdType="pmc">PMC5563280</ArticleId><ArticleId IdType="pubmed">28364279</ArticleId></ArticleIdList></Reference><Reference><Citation>Eom S., Lee B.-B., Lee S., Park Y., Yeom H.D., Kim T.-H., Nam S.-H., Lee J.H. Antioxidative and Analgesic Effects of Naringin through Selective Inhibition of Transient Receptor Potential Vanilloid Member 1. Antioxidants. 2021;11:64. doi: 10.3390/antiox11010064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11010064</ArticleId><ArticleId IdType="pmc">PMC8773328</ArticleId><ArticleId IdType="pubmed">35052566</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub I., Mohr F., Stab J., Konrad M., Philipp S., Oberwinkler J., Schaefer M. Citrus Fruit and Fabacea Secondary Metabolites Potently and Selectively Block TRPM3. Br. J. Pharmacol. 2013;168:1835&#x2013;1850. doi: 10.1111/bph.12076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12076</ArticleId><ArticleId IdType="pmc">PMC3623054</ArticleId><ArticleId IdType="pubmed">23190005</ArticleId></ArticleIdList></Reference><Reference><Citation>Manchope M.F., Calixto-Campos C., Coelho-Silva L., Zarpelon A.C., Pinho-Ribeiro F.A., Georgetti S.R., Baracat M.M., Casagrande R., Verri W.A. Naringenin Inhibits Superoxide Anion-Induced Inflammatory Pain: Role of Oxidative Stress, Cytokines, Nrf-2 and the NO&#x2212;cGMP&#x2212;PKG&#x2212;KATP Channel Signaling Pathway. PLoS ONE. 2016;11:e0153015. doi: 10.1371/journal.pone.0153015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0153015</ArticleId><ArticleId IdType="pmc">PMC4821586</ArticleId><ArticleId IdType="pubmed">27045367</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourmasumi S., Kounis N.G., Naderi M., Hosseinisadat R., Khoradmehr A., Fagheirelahee N., Kouni S.N., de Gregorio C., Dousdampanis P., Mplani V., et al. Effects of COVID-19 Infection and Vaccination on the Female Reproductive System: A Narrative Review. Balk. Med. J. 2023;40:153&#x2013;164. doi: 10.4274/balkanmedj.galenos.2023.2023-3-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/balkanmedj.galenos.2023.2023-3-4</ArticleId><ArticleId IdType="pmc">PMC10175880</ArticleId><ArticleId IdType="pubmed">37114907</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassau D.E., Best J.C., Kresch E., Gonzalez D.C., Khodamoradi K., Ramasamy R. Impact of the SARS-CoV-2 Virus on Male Reproductive Health. Bju Int. 2022;129:143&#x2013;150. doi: 10.1111/bju.15573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bju.15573</ArticleId><ArticleId IdType="pmc">PMC8444635</ArticleId><ArticleId IdType="pubmed">34402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D., Daitch V., Kalfon T., Mor M., Buchrits S., Shafir Y., Awwad M., Ghantous N., Shapira-Lichter I., Leibovici L., et al. Long COVID Sexual Dysfunction among Both Genders: Evaluation of a Cohort of COVID-19 Recoverees. Infect. Dis. Now. 2023;53:104750. doi: 10.1016/j.idnow.2023.104750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2023.104750</ArticleId><ArticleId IdType="pubmed">37406989</ArticleId></ArticleIdList></Reference><Reference><Citation>Harirugsakul K., Wainipitapong S., Phannajit J., Paitoonpong L., Tantiwongse K. Erectile Dysfunction after COVID-19 Recovery: A Follow-up Study. PLoS ONE. 2022;17:e0276429. doi: 10.1371/journal.pone.0276429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0276429</ArticleId><ArticleId IdType="pmc">PMC9584530</ArticleId><ArticleId IdType="pubmed">36264947</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack B., Von Saltza E., McCorkell L., Santos L., Hultman A., Cohen A.K., Soares L. Female Reproductive Health Impacts of Long COVID and Associated Illnesses Including ME/CFS, POTS, and Connective Tissue Disorders: A Literature Review. Front. Rehabil. Sci. 2023;4:1122673. doi: 10.3389/fresc.2023.1122673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fresc.2023.1122673</ArticleId><ArticleId IdType="pmc">PMC10208411</ArticleId><ArticleId IdType="pubmed">37234076</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechmann N., Maccio U., Kotb R., Dweik R.A., Cherfane M., Moch H., Bornstein S.R., Varga Z. COVID-19 Infections in Gonads: Consequences on Fertility? Horm. Metab. Res. 2022;54:549&#x2013;555. doi: 10.1055/a-1891-6621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1891-6621</ArticleId><ArticleId IdType="pmc">PMC9363149</ArticleId><ArticleId IdType="pubmed">35853464</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona G., Baldi E., Isidori A.M., Paoli D., Pallotti F., De Santis L., Francavilla F., La Vignera S., Selice R., Caponecchia L., et al. SARS-CoV-2 Infection, Male Fertility and Sperm Cryopreservation: A Position Statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Societ&#xe0; Italiana Di Andrologia e Medicina Della Sessualit&#xe0;) J. Endocrinol. Investig. 2020;43:1153&#x2013;1157. doi: 10.1007/s40618-020-01290-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01290-w</ArticleId><ArticleId IdType="pmc">PMC7252417</ArticleId><ArticleId IdType="pubmed">32462316</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta P., Dutta S., Roychoudhury S., D&#x2019;Souza U.J.A., Govindasamy K., Kolesarova A. COVID-19, Oxidative Stress and Male Reproduction: Possible Role of Antioxidants. Antioxidants. 2022;11:548. doi: 10.3390/antiox11030548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11030548</ArticleId><ArticleId IdType="pmc">PMC8945216</ArticleId><ArticleId IdType="pubmed">35326201</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauve F., Nampoothiri S., Clarke S.A., Fernandois D., Ferreira Co&#xea;lho C.F., Dewisme J., Mills E.G., Ternier G., Cotellessa L., Iglesias-Garcia C., et al. Long-COVID Cognitive Impairments and Reproductive Hormone Deficits in Men May Stem from GnRH Neuronal Death. EBioMedicine. 2023;96:104784. doi: 10.1016/j.ebiom.2023.104784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104784</ArticleId><ArticleId IdType="pmc">PMC10507138</ArticleId><ArticleId IdType="pubmed">37713808</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-kuraishy H.M., Al-Gareeb A.I., Alarfaj S.J., Al-Akeel R.K., Faidah H., El-Bouseary M.M., Sabatier J.-M., De Waard M., El-Masry T.A., Batiha G.E.-S. Long COVID and Risk of Erectile Dysfunction in Recovered Patients from Mild to Moderate COVID-19. Sci. Rep. 2023;13:5977. doi: 10.1038/s41598-023-32211-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-32211-5</ArticleId><ArticleId IdType="pmc">PMC10092929</ArticleId><ArticleId IdType="pubmed">37045862</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Xiao X., Zhang J., Zafar M.I., Wu C., Long Y., Lu W., Pan F., Meng T., Zhao K., et al. Impaired Spermatogenesis in COVID-19 Patients. EClinicalMedicine. 2020;28:100604. doi: 10.1016/j.eclinm.2020.100604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100604</ArticleId><ArticleId IdType="pmc">PMC7584442</ArticleId><ArticleId IdType="pubmed">33134901</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Chen J., Shi X., Li L., Xu S. Naringenin Protects Swine Testis Cells from Bisphenol A-Induced Apoptosis via Keap1/Nrf2 Signaling Pathway. BioFactors. 2022;48:190&#x2013;203. doi: 10.1002/biof.1814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1814</ArticleId><ArticleId IdType="pubmed">34914851</ArticleId></ArticleIdList></Reference><Reference><Citation>Adana M.Y., Akang E.N., Peter A.I., Jegede A.I., Naidu E.C.S., Tiloke C., Chuturgoon A.A., Azu O.O. Naringenin Attenuates Highly Active Antiretroviral Therapy-Induced Sperm DNA Fragmentations and Testicular Toxicity in Sprague-Dawley Rats. Andrology. 2018;6:166&#x2013;175. doi: 10.1111/andr.12439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.12439</ArticleId><ArticleId IdType="pubmed">29179260</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid R., Tripathi R., Singh A., Sarkar S., Kawale A., Bader G.N., Gupta S., Gupta R.K., Jha R.K. Naringenin Improves Ovarian Health by Reducing the Serum Androgen and Eliminating Follicular Cysts in Letrozole-Induced Polycystic Ovary Syndrome in the Sprague Dawley Rats. Phytother. Res. 2023;37:4018&#x2013;4041. doi: 10.1002/ptr.7860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.7860</ArticleId><ArticleId IdType="pubmed">37165686</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Xiang M., Jing H., Wang C., Novakovic V.A., Shi J. Damage to Endothelial Barriers and Its Contribution to Long COVID. Angiogenesis. 2023:1&#x2013;18. doi: 10.1007/s10456-023-09878-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-023-09878-5</ArticleId><ArticleId IdType="pmc">PMC10134732</ArticleId><ArticleId IdType="pubmed">37103631</ArticleId></ArticleIdList></Reference><Reference><Citation>Candeloro M., Schulman S. Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis. Semin. Thromb. Hemost. 2023;49:47&#x2013;54. doi: 10.1055/s-0042-1749661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1749661</ArticleId><ArticleId IdType="pubmed">35793687</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Minno A., Ambrosino P., Calcaterra I., Di Minno M.N.D. COVID-19 and Venous Thromboembolism: A Meta-Analysis of Literature Studies. Semin. Thromb. Hemost. 2020;46:763&#x2013;771. doi: 10.1055/s-0040-1715456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1715456</ArticleId><ArticleId IdType="pmc">PMC7645842</ArticleId><ArticleId IdType="pubmed">32882719</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M., Engelen M.M., Barco S., Spyropoulos A.C., Vanassche T., Hunt B.J., Vandenbriele C., Verhamme P., Kucher N., Rashidi F., et al. Incidence of Venous Thromboembolic Events in COVID-19 Patients after Hospital Discharge: A Systematic Review and Meta-Analysis. Thromb. Res. 2022;209:94&#x2013;98. doi: 10.1016/j.thromres.2021.11.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.11.029</ArticleId><ArticleId IdType="pmc">PMC8648604</ArticleId><ArticleId IdType="pubmed">34896917</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-Gon&#xe7;alves R., Hottz E.D., Bozza P.T. Acute to Post-Acute COVID-19 Thromboinflammation Persistence: Mechanisms and Potential Consequences. Curr. Res. Immunol. 2023;4:100058. doi: 10.1016/j.crimmu.2023.100058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crimmu.2023.100058</ArticleId><ArticleId IdType="pmc">PMC10083200</ArticleId><ArticleId IdType="pubmed">37064788</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., Venter C., Vlok M., Ngoepe M., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B., Pretorius E. SARS-CoV-2 Spike Protein S1 Induces Fibrin(Ogen) Resistant to Fibrinolysis: Implications for Microclot Formation in COVID-19. Biosci. Rep. 2021;41:BSR20210611. doi: 10.1042/BSR20210611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.-S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1&#x3b2;, IL-6, and TNF Cytokine Triad Is Associated with Post-Acute Sequelae of COVID-19. Cell Rep. Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological Factors and Abnormalities of Coagulation. Trends Endocrinol. Metab. 2023;34:321. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaira B., Yulianti T., Levita J. Correlation between Hepatocyte Growth Factor (HGF) with D-Dimer and Interleukin-6 as Prognostic Markers of Coagulation and Inflammation in Long COVID-19 Survivors. Curr. Issues Mol. Biol. 2023;45:5725&#x2013;5740. doi: 10.3390/cimb45070361.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cimb45070361</ArticleId><ArticleId IdType="pmc">PMC10377933</ArticleId><ArticleId IdType="pubmed">37504277</ArticleId></ArticleIdList></Reference><Reference><Citation>Malakul W., Pengnet S., Kumchoom C., Tunsophon S. Naringin Ameliorates Endothelial Dysfunction in Fructose-Fed Rats. Exp. Ther. Med. 2018;15:3140&#x2013;3146. doi: 10.3892/etm.2018.5759.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2018.5759</ArticleId><ArticleId IdType="pmc">PMC5795702</ArticleId><ArticleId IdType="pubmed">29456717</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Liu M., Liu H., Suo R., Lu C. Naringin Protects Endothelial Cells from Apoptosis and Inflammation by Regulating the Hippo-YAP Pathway. Biosci. Rep. 2020;40:BSR20193431. doi: 10.1042/BSR20193431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20193431</ArticleId><ArticleId IdType="pmc">PMC7056449</ArticleId><ArticleId IdType="pubmed">32091090</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Peng S., Xiong S., Niu A., Xia M., Xiong X., Zeng G., Huang Q. Naringin Inhibits Autophagy Mediated by PI3K-Akt-mTOR Pathway to Ameliorate Endothelial Cell Dysfunction Induced by High Glucose/High Fat Stress. Eur. J. Pharmacol. 2020;874:173003. doi: 10.1016/j.ejphar.2020.173003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173003</ArticleId><ArticleId IdType="pubmed">32045600</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright B., Spencer J.P.E., Lovegrove J.A., Gibbins J.M. Flavonoid Inhibitory Pharmacodynamics on Platelet Function in Physiological Environments. Food Funct. 2013;4:1803&#x2013;1810. doi: 10.1039/c3fo60272a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c3fo60272a</ArticleId><ArticleId IdType="pubmed">24121953</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M., Deng M., Nie W., Zou D., Wu H., Xu D. Naringenin Inhibits Platelet Activation and Arterial Thrombosis through Inhibition of Phosphoinositide 3-Kinase and Cyclic Nucleotide Signaling. Front. Pharmacol. 2021;12:722257. doi: 10.3389/fphar.2021.722257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.722257</ArticleId><ArticleId IdType="pmc">PMC8406801</ArticleId><ArticleId IdType="pubmed">34475824</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q.-Q., Yang Y.-X., Qv J.-W., Hu G., Hu Y.-J., Xia Z.-N., Yang F.-Q. Investigation of Interactions between Thrombin and Ten Phenolic Compounds by Affinity Capillary Electrophoresis and Molecular Docking. J. Anal. Methods Chem. 2018;2018:4707609. doi: 10.1155/2018/4707609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/4707609</ArticleId><ArticleId IdType="pmc">PMC5884136</ArticleId><ArticleId IdType="pubmed">29744232</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A.B., Siddiqui U., Fatima S., Rehman A.A., Jairajpuri M.A. Naringin Binds to Protein Disulfide Isomerase to Inhibit Its Activity and Modulate the Blood Coagulation Rates: Implications in Controlling Thrombosis. Int. J. Biol. Macromol. 2023;252:126241. doi: 10.1016/j.ijbiomac.2023.126241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2023.126241</ArticleId><ArticleId IdType="pubmed">37567521</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilingiris D., Vallianou N.G., Karampela I., Christodoulatos G.S., Papavasileiou G., Petropoulou D., Magkos F., Dalamaga M. Laboratory Findings and Biomarkers in Long COVID: What Do We Know so Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges. Int. J. Mol. Sci. 2023;24:10458. doi: 10.3390/ijms241310458.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241310458</ArticleId><ArticleId IdType="pmc">PMC10341908</ArticleId><ArticleId IdType="pubmed">37445634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G., Townsend L., Savinelli S., Mallon P.W.G. Long COVID: Clinical Characteristics, Proposed Pathogenesis and Potential Therapeutic Targets. Front. Mol. Biosci. 2023;10:1157651. doi: 10.3389/fmolb.2023.1157651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2023.1157651</ArticleId><ArticleId IdType="pmc">PMC10171433</ArticleId><ArticleId IdType="pubmed">37179568</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H., Peluso M.J., Rodgers K., Aberg J.A., Patterson T.F., Tamburro R., Baizer L., Goldman J.D., Rouphael N., Deitchman A., et al. Therapeutic Trials for Long COVID-19: A Call to Action from the Interventions Taskforce of the RECOVER Initiative. Front. Immunol. 2023;14:1129459. doi: 10.3389/fimmu.2023.1129459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1129459</ArticleId><ArticleId IdType="pmc">PMC10034329</ArticleId><ArticleId IdType="pubmed">36969241</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee Y.J., Fan B.E., Young B.E., Dalan R., Lye D.C. Clinical Trials on the Pharmacological Treatment of Long COVID: A Systematic Review. J. Med. Virol. 2023;95:e28289. doi: 10.1002/jmv.28289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28289</ArticleId><ArticleId IdType="pmc">PMC9878018</ArticleId><ArticleId IdType="pubmed">36349400</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese E.J., Pressman P., Hayes A.W., Dhawan G., Kapoor R., Agathokleous E., Manes P., Calabrese V. Naringin Commonly Acts via Hormesis. Sci. Total Environ. 2023;896:164728. doi: 10.1016/j.scitotenv.2023.164728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2023.164728</ArticleId><ArticleId IdType="pubmed">37295528</ArticleId></ArticleIdList></Reference><Reference><Citation>Davatgaran Taghipour Y., Hajialyani M., Naseri R., Hesari M., Mohammadi P., Stefanucci A., Mollica A., Farzaei M.H., Abdollahi M. Nanoformulations of Natural Products for Management of Metabolic Syndrome. Int. J. Nanomed. 2019;14:5303&#x2013;5321. doi: 10.2147/IJN.S213831.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S213831</ArticleId><ArticleId IdType="pmc">PMC6642644</ArticleId><ArticleId IdType="pubmed">31406461</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>